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The skeletal muscle is a terminally differentiated tissue. Its capacity to repair following 
injury or disease depends on a population of myogenic precursors, named satellite cells. 
These cells are localized beneath the skeletal muscle fiber, in a specialized 
microenvironment, the niche. The niche preserves the homeostatic conditions of satellite 
cell quiescence, but at the same time, it ensures their responsiveness to mechanical, 
physical and chemical triggers from the surrounding environment. Therefore, the 
composition of the external milieu is critical in determining satellite cell behavior. As a 
matter of fact, during aging or under pathological conditions, alterations of the 
extracellular environment entail a severe impairment of satellite cell ability to sustain 
regeneration and repair of the skeletal muscle tissue.  
The general goal of this thesis was to focus on some of the trophic factors potentially 
present in the satellite cell niche in vivo and to characterize their role on the modulation 
of satellite cell functions in vitro.  
The first part of the research activity dealt with the study of the trophic effect of ATP on 
mouse myoblast proliferation. From literature, it emerged that ATP is a potential 
regulator of the skeletal muscle regenerative program, however the signalling mechanism 
remained partially unknown. We observed that ATP increased myoblast growth rate, 
effect that was mimicked by low concentrations of H2O2. Reactive oxygen species (ROS) 
imaging revealed that ATP induced H2O2 production, at concentrations comparable to 
those effective in triggering myoblast proliferation. Interestingly, the exposure to 
equimolar concentrations of adenosine did not mimic the effect of ATP, excluding any 
role for the main hydrolysis product of ATP in the control of cell cycling. This result was in 
agreement with data reporting that the specific enzymes responsible for ATP degradation 
are poorly expressed in myoblasts and become upregulated after cell differentiation.  
In line with the latter observation, it appeared reasonable that the differentiating skeletal 
muscle cells were more exposed to ATP-derived adenosine than proliferating myoblasts, 
and this suggested a potential physiological role for the nucleoside adenosine in the later 
phases of myogenesis. Taking into account that adenosine receptors (ARs) are present in 
mouse myotubes, in a second study we hypothesized a crosstalk between nAChRs and 
ARs. Using the Ca2+-imaging technique, we observed that the pharmacological modulation 
of ARs triggered variations in the nAChR-driven ([Ca2+]i) spikes. Moreover, our preliminary 
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results suggest not only an interplay between the two receptors but also that endogenous 
adenosine is tonically released by twitching myotubes and activates its receptors.  
The third research project was aimed at exploring the role of neural agrin, a heparan 
sulphate proteoglycan, so far known as the key organizer of post-synaptic elements 
during skeletal muscle differentiation/regeneration. Besides agrin’s canonical effect on 
the maturation of the NMJ, novel roles have been discovered in the recent years, 
suggesting that the neurotrophic factor has pleiotropic effects. In this new context, we 
pursued the identification of potential new roles for neural agrin in the determination of 
satellite cell behaviour. Firstly, the analysis of different cell models, including C2C12 cell 
line and primary mouse and human cells, and revealed an increase in IL-6 secretion 
following exposure to agrin. Secondly, we addressed the hypothesis of agrin as a potential 
modulator of human myoblasts proliferation. Our preliminary results demonstrate that 
agrin enhances the proliferative capacity of human satellite cells and suggest the 
potential mechanism involved in the signaling cascade. 
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Il muscolo scheletrico è un tessuto terminalmente differenziato. La sua capacità 
rigenerativa in seguito a danno o patologia dipende da una popolazione di precursori 
miogenici, le cellule satelliti. Esse sono localizzate sulla superficie della fibra muscolare, 
racchiuse in un ambiente altamente specializzato, la nicchia. La nicchia assicura il 
mantenimento della quiescenza cellulare, ma allo stesso tempo fa sì che la cellula satellite 
risponda a stimoli meccanici, fisici o chimici, provenienti dall’ambiente esterno. Per questo 
motivo, la composizione dell’ambiente circostante condiziona altamente il 
comportamento della cellula satellite. Infatti, le alterazioni che si verificano con 
l’invecchiamento o in seguito a patologia compromettono la capacità dei precursori 
miogenici di sostenere la rigenerazione del tessuto. 
Lo scopo di questo lavoro di tesi è stato quello di individuare e caratterizzare alcuni dei 
fattori trofici che compongono il microambiente della cellula satellite in vivo, per cercare 
di capire come essi modulino le funzioni dei precursori miogenici durante la rigenerazione 
in vitro. 
La prima parte dell’attività di ricerca ha riguardato lo studio dell’effetto trofico dell’ATP 
sulla proliferazione mioblastica. Studi in letteratura hanno fatto emergere il potenziale 
ruolo regolatore dell’ATP nella rigenerazione muscolare, anche se i meccanismi attraverso 
cui opera non sono ancora chiari. I risultati da noi ottenuti hanno dimostrato che l’ATP 
aumenta la proliferazione mioblastica e che un effetto simile si osserva in presenza di 
H2O2. L’imaging per le specie reattive dell’ossigeno (ROS) ha inoltre dimostrato che l’ATP 
induce la produzione di H2O2, a concentrazioni paragonabili a quelle capaci di aumentare 
la proliferazione.  
In presenza di concentrazioni equimolari di adenosina non è stato osservato alcun effetto 
sulla proliferazione cellulare, fatto che suggerisce che il ruolo dell’ATP non sia attribuibile 
all’adenosina, il suo principale prodotto di degradazione. Questo risultato è in accordo con 
quanto già riportato da altri Autori a proposito degli enzimi responsabili dell’idrolisi 
dell’ATP: essi sono poco espressi nei mioblasti in proliferazione, mentre la loro espressione 
aumenta notevolmente con il differenziamento cellulare.  
Alla luce di queste osservazioni, risultava verosimile che i miotubi fossero più esposti 
rispetto ai mioblasti all’adenosina derivante dall’ATP e che pertanto l’adenosina avesse un 
ruolo fisiologico preponderante nelle fasi avanzate della miogenesi. Dal momento che i 
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recettori per l’adenosina (ARs) sono espressi nei miotubi murini, un secondo lavoro ha 
avuto come obiettivo quello di investigare un possibile “crosstalk” tra i ARs e i nAChRs. 
Esperimenti di Ca2+- imaging hanno dimostrato come la modulazione farmacologica dei 
ARs si traduca in una variazione nelle oscillazioni di [Ca2+]i indotte dall’attività del nAChR. 
Questi risultati, sebbene preliminari, suggeriscono non solo che i due recettori 
interagiscono tra loro, ma anche che l’adenosina è tonicamente secreta dai miotubi in 
contrazione e agisca attivando i suoi recettori.   
Il terzo progetto di ricerca è stato finalizzato allo studio del ruolo dell’agrina neuronale, un 
proteoglicano eparan solfato, già noto per la sua capacità di aggregare elementi sinaptici 
durante la fase di differenziamento e di rigenerazione del muscolo scheletrico. Accanto al 
ruolo canonico che la vede coinvolta nella maturazione della giunzione neuromuscolare, 
negli ultimi anni sono state descritte nuove funzioni per l’agrina neuronale, che la indicano 
come un fattore pleiotropico. In questo contesto, abbiamo esplorato nuove proprietà 
dell’agrina. In primo luogo, l’analisi di diversi modelli cellulari, incluse la linea cellulare 
C2C12 e cellule primarie murine e umane, ha dimostrato che il fattore neurotrofico 
potenzia il rilascio di IL-6. In un secondo studio, è stato ipotizzato un potenziale effetto di 
modulazione della proliferazione di mioblasti umani da parte dell’agrina neuronale. 
Risultati preliminari hanno dimostrato che l’agrina aumenta la capacità proliferativa delle 
cellule satelliti umane. Inoltre, sono stati individuati alcuni dei fattori molecolari che 
partecipano alla cascata di segnalazione. 
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1. The satellite cell: discovery and anatomical distribution 
 
Adult skeletal muscle is composed of highly aligned, multinucleated and cross-striated 
fibers that are terminally differentiated. Tissue homeostasis and repair depend on a 
population of muscle specific stem cells, named satellite cells.  
Satellite cells were discovered more than 50 years ago by Mauro, who noticed this 
population of mononucleated cells on the skeletal myofiber surface1. When these cells 
were discovered, it was noticed that they were distributed in a peculiar manner like a 
“satellite” at the periphery of the myofiber, thus giving rise to their name. Their specific 
localization on the skeletal muscle fiber surface suggested Mauro these cells to be 
undifferentiated precursors, capable of forming new tissue after injury. After their 
identification, when the physiological significance of these cells was still not clear, there 
were two hypotheses about their mechanism of action. It was first stated that activated 
precursors absorb the cytoplasm of the underlying damaged myofiber and gain its 
functional properties before substituting it. The second hypothesis considered satellite 
cells as specific inactivated precursors of the skeletal muscle fiber, remaining in a 
quiescent state until activation. 
To date, it is known that satellite cells reside in indentations between the sarcolemma 
and the basal lamina, in a specialized microenvironment called niche (Fig. 1)1,2. The niche 
houses these progenitor cells in their quiescent state but, at the same time, prepares 
them to be readily responsive to molecular triggers induced by physical exercise, injuries 
or disease. Furthermore, it is recognized their essential and active participation in tissue 
regeneration and their preponderant involvement in comparison to other myogenic 
skeletal muscle precursors. This is why satellite cells are considered a challenging 
opportunity in the emerging field of the regenerative medicine, and in providing new 
therapeutic strategies to cure skeletal muscle pathologies and diseases.  
Next sections will provide an overview about the process of skeletal muscle regeneration, 
how satellite cell are activated and the complex network of stimuli belonging to the 
extracellular environment that controls satellite cell behavior. 
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Fig. 1. The satellite cell is located on the skeletal muscle fiber surface and under basal 
physiological conditions is enclosed in the niche, composed by the basal lamina (apical surface) 
and plasma membrane (basal surface) of the underneath skeletal muscle cell (from [3]). 
 
 
2. The skeletal muscle regeneration 
 
The skeletal muscle regeneration consists of 4 time-dependent phases, highly 
interconnected to each other: degeneration, inflammation, regeneration and 
remodeling/repair. The successful accomplishment of each of these steps is required to 
fulfill the subsequent phase, allowing an efficient tissue regeneration process. 
 
2.1. Degeneration 
The first phase of skeletal muscle regeneration is characterized by necrosis of the 
myofiber after injury. It is due to the influx of high levels of extracellular calcium, inducing 
proteolysis of the myofibers. Although the necrotic process destroys and damages the 
tissue, it induces the activation of the inflammatory response4 and represents the first 
step towards the neo-formation of the tissue.  
 
2.2. Inflammation 
In this phase, inflammatory cells are recruited to remove the necrotic debris. Neutrophils 
are the first cells to invade the damaged site, where they rapidly release high 
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concentrations of free radicals and proteases. The oxidative and proteolytic modifications 
carried out by neutrophils promote the clearance of cellular debris by macrophages, 
which will subsequently arrive and act as new players. There are two types of 
macrophages involved in a time-dependent manner: at the beginning, M1 infiltration 
leads to the release of pro-inflammatory cytokines and of potentially harmful oxygen-free 
radicals, that can damage the tissue. Later, M2 macrophages are activated. They are anti-
inflammatory cells releasing low amounts of pro-inflammatory cytokines. The action of 
macrophages and neutrophils may lead to severe muscle damage due to the release of 
very reactive molecules. However, the role of inflammatory cells is essential for successful 
tissue turnover. In fact, alterations in the inflammatory response induced by drugs, aging 
or pathological conditions cause a severe impairment of muscle regeneration5.  
 
2.3. Regeneration 
The extensive release of growth factors and cytokines during the inflammatory phase 
induces the activation of satellite cells. The undifferentiated progenitors break cellular 
quiescence and enter the cell cycle and proliferate; later on, they stop cycling, fuse 
together and differentiate. The result is the formation of new functional myofibers6. The 
activation of satellite cells depends on several growth factors released at the injured site, 
including insulin-like growth factor-1 (IGF-1), hepatocyte growth factor (HGF), epidermal 
growth factor (EGF), transforming growth factors (TGFα and TGFβ), platelet-derived 
growth factors7 (PDGF-AA and PDGF-BB). 
 
2.4. Remodeling/repair  
The final remodeling/repair phase is characterized by the functional recovery of the 
injured skeletal muscle, together with angiogenesis and connective tissue restoration8. 
The remodeling of the extracellular matrix (ECM) has a great impact on the final outcome 
of the regenerative process. In fact, muscle injury generates an alteration of the ECM 
components, which ultimately induces the production of several types of collagens to 
accomplish remodeling9. The efficient recovery of muscle functions requires a perfect 
balance between fiber and scar tissue formation10.  
Introduction 
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3. Satellite cells and skeletal muscle regeneration 
 
As mentioned above, under basal conditions satellite cells are kept in a quiescent state, 
so that they are transcriptionally low active, with minimized oxidative stress and 
preserved mitotic potential. In fact, they have both a high amount of nuclear 
heterochromatin and nuclear to cytoplasmic ratio, few organelles and a smaller nuclear 
size, as compared to that of the adjacent myofiber2 (Fig. 2). Moreover, they exhibit 
limited gene expression and protein synthesis. 
After their activation, satellite cells become mitotically active, and from a morphological 
point of view, they are more easily identifiable. They display cytoplasmic processes to 
allow the migration along the myofiber, own a higher number of intracellular organelles, 
a lower amount of heterochromatin and an increased cytoplasmic to nuclear ratio2 (Fig. 
2).  
 
 
Fig. 2. Under normal physiological conditions the satellite cell is maintained in its sublaminar 
position in a quiescent state, displaying a high nuclear to cytoplasmic ratio, and a smaller nuclear 
size, as compared to the one of the myofiber. Upon injury of the muscle fiber, the satellite cell 
becomes activated, increases its cytoplasmic content and displays cytoplasmic processes (from 
[11]).  
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Activated satellite cells migrate outside the niche and start cycling. The descendants of 
activated satellite cells, called myoblasts, undergo multiple rounds of divisions in order to 
expand the population, and express myogenic markers. In a further phase, myoblasts stop 
cell cycle, aligned themselves and fuse together. The result is the generation of 
multinucleated cells, called myotubes, the precursors of skeletal muscle fibers. A small 
number of satellite cells doesn’t undergo the myogenic commitment12, being the fraction 
of progenitors that will replenish the satellite cell pool in the depleted niches13. 
 
3.1. Molecular characterization of satellite cells during quiescence, proliferation and 
differentiation 
Satellite cell myogenic potential relies on the expression of the paired-box transcription 
factors 3 and 7 (Pax3, Pax7) and myogenic regulatory factors (MRFs). Pax3 and Pax7 are 
important regulators of embryonic and adult myogenesis. Although their amino acidic 
sequences are very conserved, they show overlapping roles only for the myogenic 
specification.  
Pax3 function is still not well defined. During the embryonic development, Pax3 is critical 
for the delamination and migration of muscle progenitor cells from the somites to the 
limb buds14. In the post-natal period, Pax3 is progressively downregulated and remains 
detectable only in few muscle groups, such as the diaphragm and the body wall15. The 
fact that most muscles downregulate it after birth suggests that it has a minor role in 
postnatal myogenesis, although this issue remains still controversial. 
Pax7 has a more crucial function during postnatal growth with respect to Pax3 and is 
required for the myogenic specification of satellite cells16. Its expression correlates with 
an undifferentiated but committed myogenic state during the proliferative phase17 (Fig. 
3), and is required for maintenance, specification and development of satellite cells18. As 
demonstrated by knockout experiments in mice, the lack of Pax7 expression leads to 
satellite cell lost, reduction in muscle mass and defective regenerative capacity19,20.  
As soon as myoblasts approach the myogenic commitment, Pax7 is rapidly downregulated 
and other myogenic markers are activated12. Among these markers, it is noteworthy to 
mention the myogenic factor 5 (MYF5), and the myoblast determination protein (MYOD), 
which starts to be expressed during the proliferative phase21 (Fig. 3).  
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The transition of myoblasts into myocytes and myotubes is regulated by myogenin, a 
downstream target of MyoD, and MRF4 (Fig. 3). Myogenin and MRF4 are not required for 
satellite cell maintenance and activation, but their lack may compromise cell 
differentiation and myofiber formation. In particular, the inactivation of the myogenin 
gene leads to the accumulation of undifferentiated myoblasts22. 
 
 
Fig. 3. Myogenesis is a strictly orchestrated process in which activated satellite cells, called 
myoblasts, proliferate and subsequently differentiate to provide new functional myofibers. Each 
phase is tightly regulated by a specific gene expression profile that determines satellite cell fate 
(self renewal; from [23]).  
 
3.2. Satellite cell self-renewal 
The ability of self-renewal is a hallmark of stem cells and is the mechanism through which 
a copy of the parental stem cell is preserved in order to maintain a constant number of 
progenitors in a certain tissue. In the skeletal muscle, the self-renewal capability of 
activated satellite cells is an important mechanism that preserves muscle regenerative 
ability throughout adult life. 
Although, in the past, satellite cells have long been considered a homogeneous 
population of committed progenitors, the ability of satellite cells to self-renew indicates 
that they belong to a heterogeneous population of stem-like and committed cells24. In 
fact, the total number of quiescent satellite cells remains constant during multiple rounds 
of regeneration, and the balance between committed and uncommitted satellite cells is a 
peculiar feature of skeletal muscle regeneration13. This is further proven by the fact that 
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not all progenitors display the same mitotic activity. It was shown that 80% of satellite 
cells are fast-cycling, whether the last 20% represents a fraction of slow-cycling 
reservoir25. While the first are actively participating to the regenerative process, the latter 
preserve their stem-like properties. These distinct fates were observed even in 
transplantation experiments. In fact, engrafted cells were both able to be activated to 
provide new functional differentiated myofibers and to replenish the reservoir pool13,26.  
Satellite cell division may occur in a planar or in an apical-basal orientation with respect 
to the basal lamina (apical surface) and to the sarcolemma of the host fiber (basal 
surface). The orientation of cell division depends on specific elements present in the 
niche and determines the fate of the daughter cells, depending on their position within 
the niche. In the planar division, there is no polarization of the niche and both cells 
remain in contact with the basal lamina and with the myofibre; in the apical-basal 
division, a daughter cell is pushed towards the basal lamina and the other towards the 
myofibre (Fig. 4). Kuang and collaborators observed that in the basal division, the 
maintenance of the same position for the doublet of cells gives rise to two progenitors 
with the same fate (symmetric division)27. In the apical-basal division, the loss of the 
contact of one daughter with the basal lamina and the extracellular matrix leads to the 
generation of progeny with two distinct fates (asymmetric division). The hypothesis of the 
immortal strand postulates that during the asymmetrical cell division the segregation of 
DNA chromatids occurs non randomly. For each division, the DNA template of the 
parental cell is destined to only one of the two daughters, which is the self-renewing stem 
cell. Thus at every cycle, a copy of the “old” inactivated progenitor is preserved. The 
advantage of the asymmetric division is to ensure the recovery of the original stem-cell 
phenotype of the parental progenitor and to minimize the accumulation of mutations 
related to cell replication28. Unlike other stem cells, satellite cells can undergo both 
asymmetric and symmetric division; the choice between one or another depends on the 
state of injury or disease triggering satellite cell activation.  
The heterogeneous population of satellite cells can be classified depending on MYF5 
expression. Committed satellite cells are PAX7+/MYF5+ while non committed progenitors 
are PAX7+/MYF5-17. Strickingly, it was observed that planary dividing cells are either 
PAX7+/MYF5- or PAX7+/MYF5+, while cells dividing with an apical-basal orientation are 
predominantly PAX7+/MYF5- and PAX7+/MYF5+ in the basal and apical position, 
Introduction 
17 
respectively27. Committed PAX7+/MYF5+ daughters will be destined for terminal 
differentiation; Pax7+/Myf5- cells will replenish the stem cell-like reservoir (Fig. 4).  
 
 
Fig. 4. Schematic representation of satellite cell fate in symmetric and asymmetric division. 
Quiescent satellite cells are PAX7+/MYF5-. After activation, the apical-planar division distinguishes 
the genotype of the daughter cells (PAX7+/MYF5+ vs. PAX7+/MYF5-). Viceversa, the planar 
orientation of cell division gives rise to daughter cells with symmetric PAX7 and MYF5 expression 
(from [29]). 
 
 
4. The critical role of the satellite cell niche 
 
The niche is a highly specialized microenvironment profoundly affecting satellite cell 
behavior and regulating their contribution to tissue regeneration, maintenance and 
repair. As already mentioned, this specific anatomic location is composed in its apical part 
by the basal lamina, which is in direct contact with components of the ECM, and in its 
basal surface by the sarcolemma of the associated skeletal muscle fiber2. This 
microenvironment transmits biochemical and structural cues to the satellite cell and 
integrates signals from the external environment. Moreover, the niche saves satellite cells 
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from depletion, preventing excessive activation and ensuring the maintenance of a stem 
cell pool during regeneration.  
To better figure out the composition of the niche, we can imagine it to be inserted into a 
three-layered system. The so called “immediate cell niche” is constituted by the satellite 
cell itself, the myofiber and the extracellular matrix. The immediate niche is surrounded 
in turn by the so called “local milieu”, conditioned from all the neighboring cells, such as 
motor neurons, adipocytes, fibroblasts, capillaries, endothelial cells, connective tissue. 
Finally, the local milieu interacts with a broader environment, the “systemic milieu”. The 
whole integrated system provides a plethora of molecular signals, creating the instructive 
environment essential for satellite cell quiescence, as well as for proliferation, self-
renewal, commitment and differentiation during skeletal muscle regeneration30.  
The main anatomical and molecular features of the niche are described hereafter. 
 
4.1. The “immediate niche” 
As mentioned above, the “immediate niche” refers strictly to the microenvironment 
where the satellite cell is placed. The satellite cell sits on the myofiber with whom it 
communicates mechanically, physically and chemically. Due to this close relationship, the 
satellite cell is very susceptible to the mechanical activity of the underlying myofiber and, 
under specific conditions, the contractile stimulus is transduced by the satellite cells. In 
addition, physical interactions are allowed by cell adhesion proteins, which create an 
intimate contact with the myofiber. The extracellular matrix (ECM) as well is physically 
associated with the satellite cells, and its stiffness and composition contribute to the 
regulation of their behaviour. Last but not the least, the myofiber releases, often in an 
activity-dependent manner, soluble factors such as IGF, HGF, bFGF, Wnt7a, to whom 
satellite cells are exposed (Fig. 5).  
 
4.1.1. Mechanical stimuli 
In normal conditions, basal muscle contractions and relaxations occur and resident 
satellite cells are kept in a quiescent state. When muscle is injured, exercised, overused or 
mechanically stretched, these cells become activated and start the regenerative program. 
Therefore, specific mechanical changes are perceived by the myogenic precursors. For 
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example, it is well known for example that mechanical contraction of the myofiber 
triggers the production and release of nitric oxide (NO). NO affects the autocrine 
production of an important growth factor, the hepatocyte growth factor (HGF), that is a 
crucial stimulator of satellite cell activation32. 
 
 
Fig. 5. The figure shows a representation of the “immediate niche”, regulating satellite cell 
function and behavior. The satellite cell interacts physically and chemically with the underlying 
skeletal muscle fiber and with components of the ECM (modified from [31]). 
 
4.1.2. Cell-cell interactions 
Cell-cell interactions represent an important regulatory mechanism for the satellite cell 
fate. Satellite cells express cell adhesion molecules such as neural cell adhesion molecule 
(NCam), cadherins, and vascular cell adhesion protein (VCam). 
Neuronal cell adhesion molecules (NCam) are integral membrane glycoproteins, mainly 
studied to mediate interneural interactions in the peripheral and central nervous systems. 
NCam are also expressed in the skeletal muscle, where their function is to communicate 
to the nerve the status of fiber innervation. In fact, in embryonic and denervated muscle 
NCam levels are very high whereas, in adult and reinnervated muscles, NCam expression 
is reduced33. Inmmunostaining of adult skeletal muscle tissue revealed that these 
glycoproteins are concentrated at the neuromuscular junction (NMJ)34. Furthermore, 
NCam are expressed occasionally also by satellite cells and during tissue regeneration by 
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myoblasts and myotubes34, suggesting that they are also mediators of surface 
interactions of developing skeletal muscle precursors with nerve endings. 
Cadherins belong to the family of Ca2+-dependent cell adhesion molecules (Cam). Several 
subtypes of Cadherin have been identified, each one with its own pattern of distribution. 
Among them, the muscle isoform (MCad) is expressed by myogenic precursors35 and is 
located on the myofiber side. This pattern of expression suggests a role for MCad in 
stabilizing the contact between the satellite cell and the myofiber. Interestingly, during 
the regenerative program, MCad expression is upregulated and it seems to have a role in 
myoblast cell-cell interactions and recognition prior to fusion36.  
 
4.1.3.  Interconnection with the components of the ECM 
The basal lamina is composed of proteins of the extracellular matrix (ECM) that are 
mainly synthesized and secreted by interstitial fibroblasts37. The ECM molecules present 
in the basal lamina of the skeletal muscle fiber are collagen IV, laminin, entactin, 
fibronectin, perlecan, decorin glycoproteins, as well as other proteoglycans38. These ECM 
molecules are directly linked to the cytoskeleton of the satellite cell. Their binding occurs 
via α7/β1-integrins, which are expressed on the satellite cell membrane and anchored to 
the actin cytoskeleton39. These ECM components are thus crucial factors able to transmit 
physical interactions to the satellite cell, which in turn converts these signals into 
intracellular chemical ones40.  
Upon satellite cell activation, the ECM microenvironment undergoes a structural 
remodeling. In fact, the myogenic precursors have to cross the ECM barrier and abandon 
their niche to be available for tissue regeneration. The remodeling seems to occur 
through the secretion of matrix metalloproteinases (MMPs)41. MMPs belong to a family 
of zinc-dependent enzymes, and while their expression is usually inhibited in quiescent 
satellite cells through specific protease inhibitors42, they are upregulated during muscle 
injury41.  
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4.1.4. Chemical stimuli 
Myofibers and/or activated satellite cells synthesize and release molecules that act as 
trophic factors during muscle regeneration. Belong to the immediate niche: the 
hepatocyte growth factor (HGF), the fibroblast growth factor (FGF), the insulin-like 
growth factor (IGF-1) and proteoglycans.  
The HGF is released by injured myofibers and is a satellite cell activator. In more detail, 
HGF plays a critical role in the earlier stages of myogenesis, stimulating satellite cell entry 
into the cell cycle and migration43. HGF effects are mediated by c-met receptor, which is 
present on skeletal muscle cells under physiological conditions, as well as on satellite 
cells44,45 . 
The FGFs are polypeptides that build up a family of over 20 members of mitogens. These 
soluble molecules, released by myofibers and by satellite cells, contribute to tissue 
homeostasis by favoring repair and response to injury46,47. The FGF family consists of 
several isoforms that exert differential and, in some cases, still controversial roles during 
myogenesis. FGFs signaling is mediated by four distinct transmembrane tyrosine kinase 
receptors (FGFR1-4), each with a different affinity for the members of the FGF family48. 
Skeletal muscle and myogenic precursors express seven isoforms of FGF (FGF1-7). In 
particular, FGF2 and FGF6 are those playing a major role in the myogenic program49,50. 
Acting in an autocrine and/or paracrine fashion, they increase satellite cell activation and 
stimulate migration and differentiation49. The pleiotropic effect of FGFs in the skeletal 
muscle may derive from a double signaling cascade they can act through, depending of 
the expression of the receptor FGFR1 or FGFR4. Stable overexpression of FGFR1 
correlates with satellite cell proliferation and delay of differentiation. On the contrary, 
FGFR4 expression starts when myoblasts become committed to fuse and differentiate.  
Furthermore, it was shown that FGF6 is capable of inducing dedifferentiation of activated 
myogenic precursors. These observations suggest that FGF6, besides its contribution to 
skeletal muscle regeneration, owns an intrinsic mechanism to preserve a myogenic 
precursor pool from commitment, by dedifferentiation of activated myoblasts50.  
The IGF-1 gene codes for multiple isoforms of IGF-1, which are the result of 
transcriptional and splicing variants, post-transcriptional regulation and post-translational 
modifications. All these processes contribute to the production of many peptides with 
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distinct physiological roles and patterns of distribution. IGF-1 is expressed in various 
tissues, such as liver and adipose tissue, where it is mainly released as a circulating 
peptide acting in an endocrine fashion. A specific IGF-1 isoform, called “muscle-IGF-1” (m-
IGF-1) is expressed and produced by myofibers in response to injury or mechanical 
overload51,52. IGF-1 immunoreactivity was detected also in myoblasts and in myotubes53. 
Among all locally released growth factors, the attention in the few past years has 
particularly been focused on IGF-1 because of its unique pleitropic role both in 
proliferation and in differentiation of myogenic precursors.  
IGF-1 effect is mediated by its receptor IGF1R that triggers the activation of different 
signaling pathways: one drives to the phosphorylation of ERK, which is required for 
satellite cell proliferation52; the other is the AKT pathway, which drives to myoblasts 
differentiation54. It is also important to underline that the effects of IGF-1 depend on the 
origin of the molecule and that the autocrine/paracrine vs systemic mechanism of action 
of IGF-1 are independent. In fact, while the systemic infusion of IGF-1 does not affect 
muscle mass, the local administration of the growth factor is associated with muscle 
hypertrophy, selectively affecting only the muscle in which it was injected55. In vitro 
superfusion of IGF-1 to C2C12 cells induces a marked increase in cell proliferation in a 
dose-dependent manner52. Local expression of IGF-1 modulates the inflammatory 
response, favoring tissue remodeling8.  
Proteoglycans are located on the surface of satellite cells and they play a role in signal 
transduction in such a way that they regulate growth factor binding to their receptors. In 
particular, proteoglycans like syndecan3 and 4 sequester inactive growth factors, such as 
HGF, EGF, and FGF, IGF-1 and create a local reservoir to facilitate a rapid response of 
satellite cells to muscle injury56. Moreover, x-ray crystallography evidence indicates that 
HSGPs establish a double interaction with FGF receptor and are responsible for its 
dimerization and promotion of high affinity FGF binding57.  
 
4.2. The “local milieu” 
Unlike the immediate niche, the local milieu is made up of heterogeneous cell types, 
including interstitial cells, motor neurons and vascular cells (Fig. 6). 
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Fig. 6. The local milieu of the satellite cell niche is defined by all the components of the muscle 
fascicle. It is characterized by high cell type eterogeneity and it is made up of myofibers, 
interstitial cells, like fibroblasts or adipocytes, motor neurons and capillaries (modified from [30]).   
 
4.2.1. Interstitial cells 
Fibroblasts are the main components of the interstitial space, which is located between 
the basal lamina and the epymisial sheet surrounding the skeletal muscle. There is a well-
regulated homeostasis between fibroblast activity and satellite cell behavior. It was 
demonstrated that in vitro co-culturing of fibroblasts and myoblasts ameliorates and 
promotes the commitment to terminal muscle cell differentiation58. In the light of this 
observation, it has been proposed that fibroblasts actively participate to the 
microenvironment of satellite cells and contribute to muscle regeneration through the 
secretion of growth factors, such as FGF, and of ECM molecules59 (Fig. 6). 
 
4.2.2. Motor neurons 
The status of muscle innervation directly influences satellite cell behavior and 
regenerative ability. Besides the neuron-derived myofiber electrical stimulation, 
generating physical and chemical signals in the satellite cell, motor neurons (Fig. 6) also 
secrete soluble trophic factors, such as the nerve trophic factor (NTF) and the brain-
derived neurotrophic factor (BDNF). Moreover, it is a noteworth fact that in mammals 
satellite cells appear to be preferentially distributed near innervation sites60. This 
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strategic position suggests that neurotrophins and other soluble nerve-derived trophic 
factors are likely to affect satellite cell behavior particularly in mammals. In line with this, 
long-term denervation causes a dramatic decline in satellite cell number, due to reduced 
mitotic capability and to increased apoptosis61. 
It has also been found that satellite cells control motor neuron growth-cone and guide 
axon terminals to contact specialized sites on the post-synaptic cell62. The importance of 
this close relationship is even more evident during the denervation process. After acute 
denervation, satellite cell number increases, similarly to what happens during muscle 
injury.  
 
4.2.3. Vascular cells 
Blood vessels (Fig. 6) establish a close association with the skeletal muscle tissue, and it 
has been observed that satellite cells are often localized in the proximity of capillaries in 
adult skeletal muscle63. The vascular cells represent an important source of growth 
factors that interact with satellite cells, stimulating their activation, proliferation and self 
renewal. This communication is not only meant to favor skeletal muscle regeneration, but 
also to accomplish the angiogenesis process, which goes in parallel with tissue 
reconstruction. Among these soluble factors, some of them have been already described 
as components of the immediate niche as well (IGF-1, HGF, FGF)63. Besides these, the 
vascular endothelial growth factor (VEGF) is another molecule released by endothelial 
cells, promoting myoblast proliferation, differentiation and preventing apoptosis.  
 
4.3. The “systemic milieu” 
Unlike the immediate and local milieu, components of the systemic milieu, such as the 
circulating hormones or immune cells, are located away from the skeletal muscle. Hence, 
the systemic milieu triggers a quite delayed satellite cell response. 
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4.3.1. Immune cells 
In resting conditions, only a small percentage of immune cells resides in the local milieu of 
adult skeletal muscle, including mast cells and macrophages. Upon muscle injury, these 
cells act as stress-sensors and secrete chemoattractive molecules, allowing the infiltration 
of other immune cells from the systemic environment. This results in a temporary 
migration of systemic immune cells to the local milieu of the satellite cell niche. Although 
the mechanisms through which immune cells establish an interplay with muscle cells is 
not completely clear, in vitro experiments demonstrated that macrophages potentiate 
myoblast activation, proliferation, migration and that myoblasts in turn secrete cytokines 
and growth factors to potentiate immune cell infiltration64,65.  
 
 
5. The skeletal muscle regeneration during ageing 
 
At the skeletal muscle level, aging is associated with decrease in muscle mass, in strength 
and endurance, with a consequent loss of functional mobility. The term “sarcopenia” 
(from Greek, “poverty of flesh”) is generally used to describe all the abovementioned age-
related changes of the skeletal muscle. It was estimated that by 60-70 years of age, 
muscle mass decreases up to 25-30% in humans66. Aged muscles display a smaller 
myofiber cross-sectional area (CSA), an increased fibrosis and a longer time to recover 
after injury. In addition, the gradual age-associated denervation leads to a remodeling of 
motor units, with changes in fiber-type composition67,68. The pathophysiological 
implications of aging are worsened by low physical activity and training of old people68. 
Immobilized aged muscle biopsies revealed a status of myofiber degeneration 
comparable to severe pathological conditions, together with a chronic status of 
inflammation.  
The decline in neuromuscular function and performance is partially due to an impaired 
ability of myogenic precursors to contribute to tissue turnover and repair. The wide range 
of factors determining the less successful tissue regeneration in aged muscles includes 
intrinsic and extrinsic changes. Intrinsic mechanisms consist in reduction and alteration of 
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satellite cell proliferative potential, while extrinsic factors comprise the altered expression 
and release of local/systemic growth factors and cytokines.  
 
5.1. Intrinsic factors 
Satellite cells have a limited proliferative capacity, mainly due to telomere shortening. 
This is particularly evident in human cells that, unlike the murine ones, do not express 
telomerase69. In fact, cultured primary human cells display an initial active proliferation, 
rapidly declining after consecutive in vitro passages, till the proliferative senescence70. In 
addition to the reduced ability to duplicate, the senescence phase is also characterized by 
myoblast reduced mobility, capacity to fuse and to properly differentiate70,71.  
In humans, a reduction in satellite cell proliferative ability is observed during childhood. 
Neonatal and infant satellite cells are capable of more than 45 divisions, while a dramatic 
decline in the number of cycling rounds occurs after 9-15 years of age70(Fig. 7). The direct 
consequence is the reduction of available precursors and of their capacity to regenerate 
the myofiber population. 
However, contrasting estimations of aged satellite cell number are reported in literature. 
Moreover, some Authors provided evidence that the intrinsic proliferative potential, even 
if reduced in aged satellite cells, should be high enough to allow an efficient regeneration 
of skeletal muscle tissue throughout the entire adulthood71,72. Thus, the role of intrinsic 
factors in determining the impaired regenerative potential of satellite cells remains still 
matter of debate.  
 
5.2. Extrinsic factors 
Aging compromises the physiological functions of all organs in the body, and therefore 
leads to changes in the release of vascular, neural, interstitial and systemic factors.  
Accumulating evidence points out that age-specific changes depend mostly on the “age” 
of the extracellular milieu, rather than on the satellite cell per se73. Transplanting 
experiments of old muscles into young animals, during which satellite cell regeneration 
was successfully restored represent the strongest evidence for this theory74. Nowadays, 
the emerging theory is that the diminished regenerative potential of aged muscle is 
mostly due to epigenetic modifications. These changes would reflect alterations of the 
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aged environment, making the niche less permissive and sub-optimal for satellite cell 
proliferation and differentiation75,76. Even the efficiency of the inflammatory response is 
compromised by aging and immune cells with their relative secreted factors are 
significantly reduced in the satellite cell local milieu77. Other reasons that could drive to 
the generation of this sub-optimal environment are the thickening of the basal lamina, 
the increased fibrosis and the reduced capillary density. 
 
 
Fig. 7. Graph and table describe satellite cell life-span and cumulative number of divisions in 
subjects of different ages. In newborns (up to 5 months), satellite cells display a high cycling 
activity and the total number of divisions ranges from 46 to 65. After childhood (9-15 years), 
satellite cells show a decreased proliferative capacity and experience an earlier cellular 
senescence (from [70]).  
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As reported in the section “Introduction”, satellite cells are skeletal muscle myogenic 
precursors that sustain regeneration and repair of the tissue during post-natal life. Their 
behavior is significantly affected by physical, mechanical and chemical cues related to 
their surrounding environment.  
The main goal of this thesis was to investigate the effects of some of the trophic factors, 
normally released in vivo in the immediate niche and/or in the local milieu, to further 
characterize their role in the modulation of satellite cell functions and homeostasis. 
Experiments have been performed on satellite cells isolated either from mice and/or from 
humans, taking into account possible species-specific effects of the chemical signals of 
interest.  
In each of the following sections, before going into details to different research works and 
results, it will be provided a general overview of the main functional aspects of the 
trophic factors analyzed.  
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6. The role of ATP and adenosine in the regulation of myoblast 
proliferation and myotube differentiation 
 
ATP is an important signaling molecule released extracellularly by many cell types under 
resting conditions, or after pathological events. Through its autocrine/paracrine signaling, 
ATP modulates many biological functions like neurotransmission in the central and 
peripheral nervous systems, smooth muscle contraction, immune response, platelets 
aggregation, bone remodeling and more in general growth, proliferation and apoptosis78.  
At the skeletal muscle level, ATP is released by myofibers in response to the contractile 
activity79 and by the motor nerve endings during the cholinergic transmission80.  
ATP effects are mediated by purinergic receptors, that are divided into two classes, 
ionotropic (P2X)81 and metabotropic (P2Y)82. Evidences show that purinergic receptors 
are expressed by activated satellite cells and this suggests the possible role of 
extracellular ATP as a trophic factor involved in the regulation of tissue regeneration83. 
During the myogenic program, different P2X and P2Y isoforms are expressed in the 
proliferation and differentiation phases. However, in myoblasts only few receptor 
subtypes are present, while most isoforms are upregulated in differentiating myotubes84. 
This fact suggests that ATP may display a different role according to the stage of the 
myogenic program. Martinello and colleagues have proposed ATP as one of the 
controllers of myoblast proliferation84.  
Interestingly, extracellular ATP stimulation of purinergic receptors has been suggested to 
promote the production of reactive oxygen species (ROS) in the skeletal muscle85. 
Although ROS are associated with cell damage, cell death and with the pathogenesis of 
many diseases86, increasing data indicate that at low concentrations ROS, and particularly 
H2O2, play an important role as second messengers, positively regulating several cell 
functions. Regardless to the skeletal muscle, ROS are considered key modulators of 
muscle physiological functions, such as contraction, development, metabolism and blood 
flow87.  
In this scenario, one of the main questions addressed in this thesis was to investigate if 
ATP might act as an extracellular trophic factor controlling ROS production in proliferating 
myoblasts. The results obtained confirmed our working hypothesis (6.1. Appendix 1 – 
Published results). 
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It is also important to consider that that extracellular ATP has generally a short half-life 
because of its fast breakdown by multiple families of ecto-nucleotidases, located at the 
cell surface or in the extracellular matrix. Due to a different expression of ecto-enzymes 
during skeletal muscle regeneration, resting levels of extracellular ATP vary from 
myoblasts to myotubes: in the former the nucleotide’s concentrations are stably high, 
whereas in the latter it is quickly hydrolyzed because of an increased ecto-ATPase 
expression with differentiation84. The result is the prevalence of signaling molecules such 
as AMP and adenosine in the microenvironment of differentiating skeletal muscle cells in 
the later phases of myogenesis.  
In the skeletal muscle, among the purine nucleosides deriving from ATP, adenosine is 
well-known to be an important modulator of blood flow88 and of insulin-mediated 
glucose uptake89 in the skeletal muscle tissue. Moreover, adenosine derived from the 
hydrolysis of ATP released during the cholinergic signaling, mediates a depressant action 
in the neuromuscular transmission, by inhibiting ACh release from the presynaptic 
terminal90,91.  
The expression of adenosine receptors in activated myogenic precursors suggests that 
extracellular adenosine, acting in autocrine or paracrine fashion, could have an impact on 
satellite cell properties92. Therefore, it is conceivable that, besides the well known 
physiological roles of the nucleoside in the cell physiology of the skeletal muscle fibers, 
the range of functions might be extended also to the regenerative process and to the 
control of the properties of myogenic cells.  
Considering the highest level of adenosine in the microenvironment after satellite cell 
activation, it is reasonable that extracellular adenosine might play a prevalent role in 
myotube formation and/or maturation. In this context, we have also investigated the 
potential role of adenosine during skeletal muscle regeneration. Preliminary results 
suggest that adenosine modulates the nAChR-driven intracellular Ca2+ ([Ca2+]i) spikes in 
differentiated myotubes, indicating a novel role for adenosine in the differentiation of 
skeletal muscle cells and regeneration of the skeletal muscle tissue (6.2. Appendix 2 – 
Preliminary results). 
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At the developing neuromuscular junction, pre- and postsy-
naptic effects of adenosine 50-triphosphate (ATP) have been
described owing to the activity of purinergic P2 receptors [1].
ATP is stored together with acetylcholine [2,3] and co-released by
motoneurons. Moreover, ATP is also released by muscle fibers in
the extracellular environment, after mechanical distortion or
contraction [4], electrical activity [5], membrane depolarization,
or hypoxia. It acts on muscle cells as an autocrine or paracrine
signal, if coming from neighboring cells, and exerts a wide range
of cellular effects acting on P2X and P2Y purinergic receptors [6].
Recent evidence reveals that low levels of extracellular ATP
have a physiological effect also on myoblasts, the skeletal muscle
precursor cells [7,8], as well as on muscle remodeling [9] in
response to chemical and physical stimuli. Because of the low
extracellular ATP-hydrolyzing activity of the muscle myoblast
environment, ATP activity might be persistent and suggested notll rights reserved.
2
calepore).to decay easily [8] and thus is potentially able to act as a trophic
factor. In line with this, purinergic receptors are found in skeletal
myoblasts [8,10] and their expression is strictly regulated during
development and after injury [11]. In this scenario, ATP has been
suggested as a potential modulator of the regenerative capacity of
satellite cells, the resident myogenic cells responsible for muscle
adaptation in response to various stimuli, such as physical
exercise, and for tissue regeneration after injury [12,13].
At the neuromuscular junction, reactive oxygen species (ROS)
contribute to the presynaptic action of ATP [14] and, in prepara-
tions different from muscle, extracellular ATP has been hypothe-
sized to act via redox mechanisms. In astrocytes [15] and glioma
cells [16], ATP-mediated purinergic receptor activation is suffi-
cient to induce ROS production. In central nervous system
synapses, in immature hippocampus, ATP-mediated potentiation
of GABAergic synaptic transmission is mediated by ROS [17].
However, there is no evidence available on ROS-mediated ATP
action in myoblasts.
The goal of our research was therefore to investigate if ROS are
part of the signaling pathway used by low physiological levels of
ATP, working at purinergic receptors on the membrane of muscle
cells. Our results demonstrate a novel trophic effect of ATP on the
M. Sciancalepore et al. / Free Radical Biology and Medicine 53 (2012) 1392–1398 1393growth of mouse myoblasts and suggest the redox agent hydro-
gen peroxide (H2O2) as an important intermediate downstream of
ATP receptor pathways leading to enhanced cell proliferation of
muscle precursors. New findings related to the physiological
effects of ROS open new perspectives for the comprehension of
skeletal muscle excitability, plasticity, and regeneration.Materials and methods
Cell culture
Primary myoblast cell cultures were established from mouse
satellite cells, kindly provided by Professor A. Wernig (University
of Bonn; for details see [18]). Briefly, cells were isolated from the
hindleg of 7-day-old male Balb/c mice killed by cervical disloca-
tion as approved by the local Animal Care Committee and in
agreement with European legislation. Muscle tissue was minced
and then enzymatically dissociated with collagenase and trypsin.
Expansion and enrichment of myoblasts were achieved and
experiments were performed on cell cultures showing a myogenic
purity higher than 90%, tested by desmin immunofluorescence
staining, as previously described [19]. Myoblasts were maintained
as exponentially undifferentiated cells [20] in growth medium
(GM) consisting of Ham’s F-10 supplemented with 20% fetal calf
serum, 4 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml
streptomycin and subcultured by standard trypsinization every
3 days. Cultures were grown at 37 1C and 5% CO2.
Cell proliferation and fusion
To evaluate cell proliferation, subcultured undifferentiated
myoblasts at a density of 3103 cells in 35-mm-diameter petri
dishes were exposed to various stimuli 24 h after seeding in GM.
Proliferation was measured 3 days after stimulation. The prolif-
erative capacity was expressed as mean percentage increase in
cell number with respect to controls (unstimulated cells), from at
least three independent experiments performed in triplicate.
To induce cell differentiation and fusion, mononucleated
myoblasts were plated at a density of 70103 cells on 24-mm
coverslips coated with Matrigel. Twenty-four hours after plating,
the GM was replaced with differentiation medium (DM) consist-
ing of Dulbecco’s modified Eagle’s medium supplemented with 2%
horse serum and L-glutamine, penicillin, and streptomycin as for
GM. DM was renewed every 2 days. The myoblast differentiation
efficiency was quantified after 6 days in DM by evaluating the
fusion index, defined as the number of myotube nuclei vs the
number of total nuclei. Myogenic cells were labeled with desmin
immunofluorescence staining, marking the nuclei with bis-
benzimide H-33258 [19]. Quantification of nuclei was performed
from at least 10 randomly chosen optical fields per coverslip for
four independent experiments.
Calcium imaging
Intracellular calcium concentration ([Ca2þ]i) was monitored
using the fluorescent Ca2þ indicator fura-2 pentacetoxymethyl
ester (Fura-2 AM). Myoblasts were plated on Matrigel-coated
coverslips and loaded with the Ca2þ indicator Fura-2 AM (5 mM,
30 min in the dark) at room temperature, in a normal external
solution (NES; see below) supplemented with 1 mg/ml bovine
serum albumin. After washout, the cells were maintained in NES
for 15 min at room temperature to allow deesterification of the
dye. A temperature-controlled microincubator chamber (Medical
Systems Corp.; Davie, FL, USA) kept the temperature at 371C
during the experiments. Cells were excited alternately at 340 and380 nm, selected by a monochromator (Polychrome II Till Photo-
nics GmbH, Martinsried, Germany) and fluorescence signals were
collected by a CCD camera (SensiCam; PCO Computer Optics,
Kelheim, Germany) at an image acquisition rate of 1 ratio/s. The
monochromator and CCD camera were controlled by Till Vision
software (Till Photonics), also used for image processing. The ratio
of fluorescence images (340/380) and the corresponding temporal
plots (i.e., variations in the mean value of the fluorescence
intensity obtained from regions of interest) were calculated off-
line. In the temporal plots, the fluorescence ratio at rest was
assumed to be 1. Variation in the [Ca2þ]i was expressed in the
plots as increase in fluorescent signal relative to the fluorescence
at rest. Each set of experiments was carried out in at least three
different cell preparations. The number of analyzed cells for each
experimental point exceeded 40.
ROS measurement
Myoblasts were plated into black optical-bottom 96 wells, at a
density of 12.5  103 cells/well. ROS measurements were carried
out 24 h after plating as previously described [21]. Briefly, cells
were loaded with 2 mM 5-(and-6)-carboxy-20,70-dichlorodihydro-
fluorescein diacetate (carboxy-H2DCFDA; Invitrogen, Carlsbad,
CA, USA) for 30 min at 371C in Hepes-buffered salt solution. After
washout, the cells were acutely stimulated with 10 mM ATP and
immediately analyzed online for ROS generation. In some experi-
ments myoblasts were preincubated with diphenyleneiodonium
chloride (DPI; 25 mM, 60 min) or catalase (1200 U/ml, 15 min).
H2O2 (3 mM) was used as reference control. DCF in vivo fluores-
cence imaging was assessed using a fluorimeter (PerkinElmer,
Waltham, MA, USA) every 5 min up to 30 min at 371C. Fluores-
cence was expressed as F/F0, where F was the fluorescence signal
after 15 min and F0 the baseline fluorescence value of the same
wells before stimulation. Mean changes in fluorescence were
expressed as percentage of control. For each stimulus, ROS
measurement was performed in triplicate, and the data represent
the means of three independent experiments.
Cell viability
Cell viability was assessed by 3-(4,5-dimethylthiazole-2-yl)-2,5-
biphenyltetrazolium bromide (MTT [22]) and sulforhodamine B (SRB
[23]) assays. Cells were seeded into 96-well plates at 12.5103 cells/
well in GM. After 24 h, the cells were exposed to 3 or 100 mM H2O2
for 30 min, then the H2O2 was washed out and GM was renewed.
MTT and SRB assays were performed 24 h after stimulation.
For MTT assay, cells were incubated for 5 h in 20 ml/well of a
5 mg/ml MTT solution. The medium was then removed by
vacuum aspiration, and cellular formazan crystals were dissolved
with dimethyl sulfoxide (200 ml/well). Absorbance was measured
on an Automated Microplate Reader EL 311s (Bio-Tek Instru-
ments, Winooski, VT, USA) with a reference wavelength of
630 nm and a test wavelength of 540 nm.
For SRB assay, cells were washed twice with phosphate-
buffered saline (PBS; 100 ml/well) at room temperature and then
fixed with a 50% trichloroacetic acid solution (50 ml/well) for
60 min at 4 1C. After 1 h, the wells were rinsed twice with
bidistilled water (100 ml/well) and incubated with SRB (0.4% in
1% acetic acid, 100 ml/well) for 30 min at room temperature. After
three washouts with 1% acetic acid (100 ml/well) to eliminate
colorant excess, the cells were solubilized with tris(hydroxy-
methyl)aminomethane (10 mM, 200 ml/well). Sample absorbance
was read on the Automated Microplate Reader EL 311s with a
single wavelength of 570 nm. MTT and SRB assays were per-
formed at least three times in 15 replicate wells for each H2O2
concentration.
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Freshly prepared hydrogen peroxide was diluted in GM from a
40% (w/v) stock solution. The physiological solution (NES), PBS,
and Hepes-buffered salt solution (HBSS) contained (in mM): NES,
NaCl 140, KCl 2.8, CaCl2 2, MgCl2 2, glucose 10, Hepes 10 (pH
adjusted to 7.35 with NaOH); PBS, Na2HPO4 10; NaH2PO4 1.8,
NaCl 145; and HBSS, NaCl 120, KCl 5.4, CaCl2 1.8, glucose 10,
NaHCO3 25, Hepes 25. Media, horse serum, antibiotics, and
L-glutamine were purchased from Sigma (St. Louis, MO, USA).
Fetal calf serum was from Mascia Brunelli (Milan, Italy), Matrigel
from Becton–Dickinson (Rutherford, NJ, USA), and CGS-15943
from Tocris Bioscience (Bristol, UK). All the other chemicals,
unless otherwise stated, were from Sigma.
Data acquisition and statistical analysis
All data are presented as the means 7 SE with n being the
number of petri dishes, unless otherwise stated. GraphPad Prism
4 (GraphPad Software, San Diego, CA, USA) software was routinely
used for statistical analysis and graph plotting. Differences
between data were evaluated by one-way ANOVA, followed by
Bonferroni’s post hoc test.Results
Extracellular ATP affects myoblast proliferation
To test the possible role of extracellular ATP on muscle
satellite cell proliferation, primary cultures of mouse myoblasts
maintained in GM as undifferentiated exponentially growing cellsFig. 1. Promotion of myoblast proliferation by ATP. (A) Representative images of
fluorescence micrographs of mouse myoblasts stained for desmin (red) grown
under control conditions and after treatment with 10 mM ATP (nuclei are stained
in blue with bis-benzimide); note increase in number of cells. Scale bars, 100 mm.
(B) Dose–response relationship of the effect of ATP on myoblast proliferation (see
the text for details). np o 0.05, significantly different from the untreated controls.
(For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)were exposed to various doses of the nucleotide. Fig. 1 shows that
the growth rate of mouse myoblasts was significantly increased
only by chronic treatment with 1 or 10 mM ATP (respectively
26.37 7 5.77%, n ¼ 10, and 22.60 7 2.29%, n ¼ 68, increase with
respect to the controls; p o 0.05) at day 4. Interestingly, even
after a single and short exposure (30 min, data not shown) to
10 mM ATP we still observed the stimulatory effect of the
nucleotide on myoblast proliferation (29.10 7 3.66%, n ¼ 27,
p o 0.05, data not shown). In myoblasts treated chronically with
very low (0.1 mM) or relatively high (100 mM) concentration of
ATP, the cell number at day 4 did not change significantly
compared with controls (0.63 7 5.41%, n ¼ 5; 4.70 7 2.91%,
n ¼ 8, respectively). Interestingly, very high concentrations of
ATP (1 and 3 mM) significantly reduced the proliferative capacity
of myoblasts in a dose-dependent manner (45.6 7 2.33%, n ¼
5; 95.7 7 1.06%, n ¼ 6; of control, respectively, p o 0.05).
The ATP-induced myoblast proliferation is mediated by P2 receptor
activation
Preincubation (15 min) with 100 mM suramin prevented the
effect of 10 mM ATP on cell proliferation. The number of myo-
blasts was 8.46 7 3.59% of controls (n ¼ 10), significantly
different from that observed in cells treated with ATP alone
(19.61 7 3.19% of controls, n ¼ 15; p o 0.01). Treatment with
100 mM suramin alone, however, did not significantly change
myoblast proliferation (8.66 7 4.97%, n ¼ 14; Fig. 2A). To
exclude the possibility that the mitogenic effect of 10 mM ATP was
mediated by adenosine, we also explored the direct effect of this
ATP derivative on myoblast proliferation. However, the equimolar
(10 mM) concentrations of adenosine did not affect cell prolifera-
tion (0.93 7 1.85% of controls, n ¼ 9; p 4 0.05). In addition,Fig. 2. Mitogenic effects by purinergic P2 receptor stimulation. (A) When present
in the medium, 100 mM suramin inhibited the mitogenic effect of 10 mM ATP.
Suramin, per se, did not significantly change the myoblast proliferation. (B) The
adenosine receptor antagonist 100 nM CGS-15943 did not influence the effect of
ATP, and 10 mM adenosine showed no effect on cell growth. np o 0.05,
significantly different from the ATP-treated cells.
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(100 nM) did not inhibit the effect of 10 mM ATP on cell prolifera-
tion (18.03 7 2.39%, n ¼ 10 vs 21.80 7 3.13% in ATP alone, n ¼
15; p 4 0.05; Fig. 2B). These results suggested that the trophic
effect of ATP on myoblast proliferation was triggered by activa-
tion of P2 receptors.
To investigate the extracellular ATP signaling pathway, Ca2þ
imaging experiments were performed. Superfusion of 10 mM ATP
induced spontaneous [Ca2þ]i oscillations in the majority of
cultured mouse myoblasts tested (85.65 7 6.04%, n ¼ 5).
Fig. 3A illustrates typical ATP-induced Ca2þ oscillatory patterns.
In the presence of ATP alone, [Ca2þ]i responses progressively
decreased in amplitude. A complete recovery of basal [Ca2þ]i was
thus observed within 5 min of the onset of the oscillatory activity
(mean 299.42 7 12.59 s, n ¼ 51 cells). The addition of the Ca2þ
chelator EGTA (5 mM) to the bathing medium did not prevent
ATP-induced Ca2þ oscillations. The number of ATP-responsive
cells was not affected (80.25 7 8.24%, n ¼ 5, Fig. 3B), indicating
that the ATP-induced Ca2þ response did not depend on Ca2þ
influx.
Preincubating the cells with the broad purinergic P2 receptor
antagonist suramin (100 mM), however, drastically reduced the
number of cells responsive to ATP (1.00 7 0.29%, n ¼ 3),
confirming the direct action of ATP via P2 receptors. All these
data suggest a prevalence of purinergic P2Y receptors in prolifer-
ating myoblasts.ATP induces ROS generation
Because the action of ATP in adult muscle is mediated by the
induction of ROS [17], we next tested if the action of ATP was
ROS-dependent also in proliferating myoblasts. To directlyFig. 3. . [Ca2þ]i responses induced by ATP. (A) Representative spontaneous [Ca
2þ]i os
presence of 10 mM ATP alone, with 5 mM EGTA, and with 100 mM suramin. Ordinates
responsive cells under the three different experimental conditions shown in (A). ATP ind
absence (5 mM EGTA) of external Ca2þ , whereas suramin prevented the ATP-induced [Cinvestigate whether ATP triggered ROS generation, we utilized
the fluorescence probe carboxy-H2DCFDA, commonly used to
detect ROS formation in living cells [24]. Myoblasts exposed to
10 mM ATP exhibited a significant and fast change (33.68 7
7.68%, p o 0.01, 15 min after stimulation) in the fluorescent
signal, indicating a fast increase in endogenous ROS. Interestingly,
a similar (34.77 7 15.53%) increase in fluorescence was observed
after adding 3 mM H2O2 as a positive control (Fig. 4A, p o 0.05).
Furthermore, cell preincubation with the peroxide scavenger
catalase (1200 U/ml, 15 min) prevented the ATP-induced ROS
production (p o 0.05).
The role of NADPH oxidase as a possible source of ROS elicited
by ATP was also investigated. To inhibit the endogenous NADPH
oxidase, myoblasts were preincubated with DPI (25 mM) for
60 min. Pretreatment with DPI blocked the ATP-elicited increase
in intracellular fluorescence (Fig. 4A, p o 0.01). These results
indicate that in cultured myoblasts the NADPH oxidase complex
was involved in the generation of ROS as an intermediate of ATP-
mediated signaling.Role of ROS in the trophic effect induced by ATP
A set of experiments was planned to investigate if ROS
promoted the ATP-induced myoblast proliferation. Preincubation
(15 min) with the H2O2 scavenger enzyme catalase (1200 U/ml)
prevented the ATP-mediated cell proliferation (5.94 7 3.29% vs
22.28 7 7.04% in ATP, n ¼ 13; p o 0.001; Fig. 4B) without any
effect on cell number per se (2.86 7 4.28% of control, n ¼ 15;
p 4 0.05). In parallel, myoblasts were exposed to various
concentrations of H2O2 (0.1, 3, 30, and 100 mM) and a bell-
shaped concentration-dependent effect of H2O2 on myoblast
proliferation was observed. The lowest efficacious concentrationcillatory patterns observed under three different experimental conditions: in the
represent the fluorescence increase relative to the value at rest. (B) Percentage of
uced [Ca2þ]i oscillations in similar numbers of cells both in the presence and in the
a2þ]i response.
np o 0.05, significantly different from the ATP-alone-treated cells.
Fig. 4. ROS-mediated extracellular effects of ATP. (A) Similar changes in DCF
fluorescence in myoblasts over 15 min exposure to 10 mM ATP and to 3 mM H2O2
revealed ROS production in cultured mouse myoblasts. Preincubation with DPI
(25 mM, 60 min) or catalase (1200 U/ml, 15 min) blocked the effect of ATP on ROS
production. The data are plotted as the mean fold increase (7SE) over untreated
controls. (B) Treatment of proliferating myoblasts with 10 mM ATP significantly
increased the number of cells. Pretreatment with the H2O2 scavenger catalase
prevented the rise in growth rate induced by ATP. Catalase per se did not
significantly change the cell proliferation. np o 0.05, significantly different from
the untreated controls; #p o 0.05, significantly different from the ATP-treated cells.
Fig. 5. H2O2 effects on myoblast proliferation. A significant increase in myoblast
growth rate was observed in cultures treated with 3 (p o 0.05) and 30 mM (p o
0.05) H2O2, but not with 0.1 or 100 mM (p 4 0.05) H2O2.
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10; p o 0.05). H2O2 at 30 mM induced a smaller but still
significant effect (10.00 7 3.86%, n ¼ 25, p o 0.05), whereas
100 mM H2O2 did not (4.70 7 2.89% of control, n ¼ 5; p 4 0.05;
Fig. 5). Therefore, similar to ATP, H2O2 improved myoblast
proliferation only at low concentrations.
Both SRB and MTT assays were performed on cells exposed to
3 and 100 mM H2O2 for 30 min (see Materials and methods for
further details). In the presence of 3 mM H2O2, the SRB assaydetected protein content that was significantly (p o 0.05) higher
than in controls, whereas no significant effect was observed in cell
cultures treated with 100 mM H2O2 (p 4 0.05; data not shown).
The MTT assay excluded any toxic effect on cell viability at both
H2O2 concentrations (data not shown). These data confirmed the
enhancing effect of 3 mM H2O2 on myoblast proliferation and
excluded any toxic effect of H2O2 in the concentration range used
for our experiments.
Nevertheless, under the same conditions H2O2 did not affect
myoblast differentiation as demonstrated by unaltered differen-
tiation efficiency, evaluated by calculating the fusion index at
6 days in culture, in controls and in cultures treated for 30 min
with 3 and 100 mM H2O2. The fusion index values revealed that
neither H2O2 concentration affected the ability of myoblasts to
form multinucleated myotubes (controls 20.88 7 1.84%; 3 mM
H2O2 18.21 7 2.46%; 100 mM H2O2 24.50 7 2.22%; data not
shown). The unaltered fusion index seemed to exclude a side
effect of low concentrations of H2O2 on differentiation capability
of myoblasts and confirmed that H2O2 was not toxic in the
concentration range used.Discussion
Despite its well-known role as an intracellular energy source,
ATP released by skeletal muscle during electrical activity [5] could
induce short-term or long-term changes in the muscle by acting
on membrane purinergic receptors. ATP might therefore work as
an intercellular signaling molecule, favoring muscle regeneration
via the proliferation and differentiation of satellite cells [25].
This study reports for the first time a ROS-mediated stimula-
tory effect of extracellular ATP on the proliferation rate of mouse
skeletal myoblasts derived from satellite cells.
ATP promotes proliferation of skeletal myoblasts
We observed that physiological levels of extracellular ATP (1–
10 mM) [9,26,27] induce a more than 20% increase in proliferation
of mouse myoblasts. A lower concentration (0.1 mM) was not
enough to be effective, whereas higher doses (1 and 3 mM)
reduced cell growth. We can argue that at high concentration,
ATP can operate via different purinergic receptors, triggering
different functional effects. In the concentration range promoting
cell proliferation, our results indicate that ATP acts via suramin-
sensitive P2 receptors. The expression of P2 receptors in skeletal
myoblasts was previously reported by several groups [7,8,28,29].
In proliferating myoblasts, under our experimental conditions,
application of ATP elicited [Ca2þ]i oscillations, which were inde-
pendent of external Ca2þ , indicating a cell signaling based mainly
on Ca2þ release from internal stores. This effect is consistent with
the involvement of metabotropic P2Y receptors, which are nor-
mally coupled with inositol trisphosphate (IP3)-dependent Ca2þ
release from intracellular reservoirs.
Effects of ATP on cell proliferation have been previously
reported, even though conflicting results were obtained. Recently,
the proliferative action of ATP via P2X and P2Y receptors was
found in C2C12 skeletal myocytes maintained in differentiation
medium [8]. However, in primary cultures and in C2C12 muscle
cells, extracellular ATP at relatively high 100 mM concentration
inhibited proliferation, favoring myoblast differentiation into
myotubes [10,30]. In addition, in primary cultures, 10 mM ATP
did not inhibit cell proliferation in a serum-enriched medium, in
which immunoreactivity for P2X was not detected [10]. More-
over, the same authors reported that in general, P2Y receptor
agonists did not inhibit myoblast proliferation. In particular, and
in accord with our suggestions on P2Y-promoted proliferation,
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increased the skeletal myocyte number [8,10]. The apparent
discrepancy in the action of extracellular ATP on myoblast
proliferation could therefore be explained by the fact that various
purinergic receptor subtypes could be expressed in different
muscle cell lines as well as under different serum conditions.
The possibility that the ATP derivatives ADP and AMP could be
contributing to the observed positive ATP-related changes in
myoblast proliferation was also considered; however, it is known
that cultured myoblasts have low ATP-hydrolyzing activity by
ecto-ATPases, which is suggested to preserve cell viability
because AMP and ADP were found to show cytotoxic effects in
C2C12 cells [8]. We also demonstrated that the ATP-mediated
proliferation was not due to the conversion of ATP into its
principal end metabolite adenosine. In neither case did the
adenosine receptor antagonist CGS-15943 affect the ATP-
mediated myoblast proliferation, and adenosine per se did not
alter the growth rate of proliferating myoblasts, as already
observed by other groups [10].ROS-dependent action of purines in skeletal muscle
ROS are also produced by skeletal muscle during exercise [31].
Here, we tested whether ATP signaling leading to enhanced
myoblast proliferation is mediated by a ROS-dependent mechan-
ism. Three lines of evidence are consistent with such a mechan-
ism. First, ROS imaging with the H2O2-sensitive dye DCF revealed
that exogenous ATP induced ROS generation. The similar intra-
cellular fluorescence increase induced by 3 mM H2O2 is consistent
with the fact that in mouse myoblasts purinergic receptor
activation allows the production of peroxides at comparable
low-micromolar concentrations. Second, the proliferative effect
of ATP was prevented after breaking down of extracellular H2O2
by the membrane-impermeative catalase. Our results are consis-
tent with previous experiments suggesting that the enzyme, even
if added extracellularly, controls the intracellular redox status,
because H2O2 can freely diffuse across cell membranes [32]. Third,
low-micromolar concentrations of exogenous H2O2 mimicked the
stimulatory effect of ATP on myoblast growth. A similar stimula-
tory effect was also observed in fibroblasts, bacteria [33], yeast
cells [34], and pulmonary artery endothelial cells [35]. Thus, H2O2
represents a key signaling molecule during myogenesis [36], able
to promote muscle cell regeneration.
The main sources of ROS in mammalian cells are mitochondria
and oxidases, including NADPH oxidase. Recent studies show that
H2O2, generated after activation of the endogenous NADPH
oxidase, favors the proliferation of myoblasts [37]. Furthermore,
ROS produced by NADPH oxidase mediated mitogenic factor
signaling pathways in leiomyoma cells [38].
In line with these results, our data indicate that the intracel-
lular mechanisms coupling activation of purinergic receptors and
H2O2 generation in mouse skeletal myoblasts involve NADPH
oxidase activation. The specific target for H2O2-mediated mito-
genesis in skeletal myoblasts has not yet been found; plasma
membrane receptor tyrosine kinases [39] as well as ion channel
conductances [40] can be potentially involved.Conclusions
In line with previous studies, such as the regulation of synaptic
transmission at peripheral and central synapses [14,17], the
promotion of tumor growth [16], and the modulation of macro-
phage immune responses [41], our results show a ROS-mediated
action of extracellular ATP.Here, a link between the activation of purinergic receptors by
physiological levels of extracellular ATP, generation of NADPH
oxidase-derived ROS, and potentiation of regenerative capability
of skeletal muscle cells is revealed. Our data therefore support the
intriguing hypothesis that ROS, well known to induce tissue
damage under oxidative stress conditions (massive exercise,
aging, and muscle disease), might promote muscle plasticity
and regeneration if generated at low concentrations.Acknowledgments
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Adenosine receptors affect the nAChR-driven [Ca2+]i spikes in 
differentiating myotubes 
 
Introduction 
During myogenesis, differentiating rodent skeletal muscle cells display a contractile 
activity in the absence of innervation. It was already demonstrated that these twitches 
are sustained by [Ca2+]i spikes that mainly depend on the upstream autocrine activity of 
the nAChRs93. In fact, differentiating skeletal muscle cells synthesize and release ACh-like 
compounds94. It has also been demonstrated that such nAChR-driven ([Ca2+]i) spikes 
represent a crucial mechanism through which the differentiating muscle cell maintains its 
own trophism before innervations95.  
Adenosine signaling occurs through the activation of purinergic P1 receptors, named 
adenosine receptors (ARs). They represent a family of four G-protein coupled receptors, 
A1, A2A, A2B, A3, displaying different expression patterns and affinity for adenosine
96. 
Among the activities mediated by the ARs, there are those involving the modulation of 
the metabotropic and ionotropic neuroreceptors at the central and peripheral synapses97. 
At the skeletal muscle level, very little is known about the expression and action of ARs, 
both during development and adult age. Interestingly, in rat myotubes, ARs were 
proposed to modulate nAChR channel activity98. However, the role of adenosine in 
controlling the nAChR-driven ([Ca2+]i) spikes has never been studied.  
Taking into account all these observations, we have performed an analysis of the AR-
mediated effects on the nAChRs-driven spontaneous [Ca2+]i spikes and on the autocrine 
nAChR channel opening activity in in vitro differentiated mouse myotubes.  
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Methods  
Cell culture 
The experiments were performed on myotubes derived from the in vitro fusion and 
differentiation of expanded primary mouse myoblasts (called i28), kindly supplied to us by 
Dr A. Wernig, Department of Physiology and Medical Policlinic, University of Bonn, 
Germany. Briefly, these myogenic cells were plated at a density of 70000 cells either in 24 
mm Matrigel-coated coverslips, or in 35 mm Matrigel-coated Petri dishes. Cells were 
maintained in proliferative conditions in the presence of HAM’S F-10 growth medium, 
plus 20% fetal bovine serum (FBS), l-glutamine (2 mM), penicillin (100 units/ml), and 
streptomycin (100 g/ml). To induce cell differentiation and fusion into myotubes, 1 day 
after plating the growth medium was replaced with a differentiation medium, consisting 
of DMEM supplemented with 2% horse serum and l-glutamine, penicillin and 
streptomycin. The differentiation medium was renewed every 3 days to avoid loss of 
nutrients and growth factors. Cultures were maintained at 37 °C in a humid air 
atmosphere containing 5% CO2.  
 
Videoimaging 
Videoimaging experiments were carried out as described in detail in Appendix I99. During 
[Ca2+]i measurements, drugs were gently applied to the bathing solution by loading 
appropriate volumes of concentrated solution into a 2-ml syringe connected to the micro-
incubator chamber via a small tube. 
 
Electrophysiological recordings 
Single channel recordings in cell-attached configuration were performed, at room 
temperature, in 6- to 8 day differentiated myotubes, when cells were able to generate 
spontaneous mechanical contractions, as previously reported by our lab100,101. Cells were 
bathed in a normal external solution (NES) containing (mM): NaCl (140), KCl (2,8), CaCl2 
(2), MgCl2 (2), glucose (10), Hepes (10), pH 7.4. The patch pipettes were made up of 
borosilicate glass and fire-polished to a final tip resistance of 5-8 M  when filled with the 
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same NES. Single channel currents were recorded using an Axopatch 200 amplifier. 
Signals were filtered at 1 kHz with a lowpass Bessel filter and analyzed post-acquisition by 
using the pCLAMP 8.0 software package (Axon Instruments).  
Control and experimental data were collected immediately after achieving the gigaseal, 
when the single channel activity was stable. To examine with accuracy the channel open 
time, only traces with single openings were considered for analysis. Channel conductance 
was estimated from the slope of the regression line obtained by plotting the current 
amplitude against the pipette potentials (Vp) at 40, 60, and 80 mV. All kinetic analysis 
were performed at 60 mV pipette potential. The resting membrane potential was 
calculated under cell-attached configuration, by recording the activity of nAChR channels 
at different pipette potentials, assuming AChR reversal potential at 0 mV. Data were 
analysed using SigmaPlot software (OriginLab Corporation, Northampton, MA, USA) and 
are given as means ± SEM; data sets are considered statistically different when p < 0.05 
(ANOVA Bonferroni’s post hoc test).  
 
Chemicals 
Fetal calf serum was purchased from Life Technologies (Monza MB, Italy) and Matrigel 
from Becton–Dickinson (Rutherford, NJ, USA). Adenosine ligands were purchased by 
Tocris Bioscience (Bristol, United Kingdom) and ADA was from Roche S.p.A. (Milano, 
Italy). All the other chemicals, unless otherwise stated, were from Sigma (St. Louis, MO, 
USA). 
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Results  
AR ligands modulate the nAChR-driven [Ca2+]i spikes 
As previously reported, autocrine nAChR activity activates the excitation-contraction 
coupling mechanism with the generation of [Ca2+]i spikes and contractions
95. To verify 
whether the AR-mediated activity could modulate the embryonic nAChR channel 
openings, videoimaging experiments were performed in presence of non-specific AR 
ligands, namely the agonist NECA (100 M), the stable adenosine analogue, and the 
antagonist CGS 15943 (100 nM). Calcium imaging experiments revealed that NECA 
increased the [Ca2+]i spiking frequency in 65.00 ± 10.00% of cells observed (n = 5 optical 
fields, 19 cells), and CGS 15943 completely abolished the activity in all the spiking cells 
analysed (n = 3 optical fields, 8 cells), indicating that the AR-activity affected the 
functional phenomena driven by the nAChR (Fig. 1).  
 
 
Fig. 1. Effect of NECA and CGS in nAChR-driven [Ca2+]i spikes. The ARs agonist NECA 100 µM 
induced an increase in the [Ca2+]i spiking frequency, while the ARs antagonist CGS 15943 blocked 
[Ca2+]i transients.  
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Endogenous adenosine promotes [Ca2+]i spiking activity 
To test whether the endogenous content of adenosine, released by contracting 
myotubes, was in the concentration range efficacious to modulate nAChR-driven [Ca2+]i 
spiking activity, a series of experiments was carried out in presence of adenosine 
deaminase (ADA), the enzyme that catalyzes the irreversible deamination of adenosine to 
inosine, a molecule unable to activate ARs. Pre-incubation with ADA (U/ml, 60 min at RT) 
caused a significant reduction in the spontaneous [Ca2+]i spikes of twitching myotubes. 
Specifically, ADA blocked or significantly inhibited the frequency of [Ca2+]i spiking activity 
in 87.50  5.99% of the cells observed (n = 6 optical fields; 21 cells; Fig. 2).  
 
 
Fig. 2. Effect of the degradation of extracellular adenosine. ADA induced either a block or an 
inhibition the frequency of nAChR-driven [Ca2+]i spiking activity. ADA was added to spiking 
myotubes and pre-incubated for 60 min before [Ca2+]i measurements. 
 
Role of the different AR subtypes on nAChR channel activity  
In order to assess the specific role of each AR subtype, videoimaging experiments were 
performed on spiking myotubes treated with selective AR antagonists: ANR94 (100 nM) 
for the A2AR, MRS1764 (20 nM) for the A2BR, and ANR235 (100 nM) for the A3R. While cell 
superfusion with inhibitors for A1R, A2AR and A3R did not affect [Ca
2+]i spiking, the A2B 
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antagonist MRS 1754 blocked the phenomenon in 66.67  23.57% of the cells (n = 4 
optical fields; 10 cells; Fig. 3).  
 
Fig. 3. Effect of specific A2BRs antagonist. The selective inhibition of the A2BR by 20 nM MRS 1754 
induced a decrease in [Ca2+]i spiking activity of twitching myotubes.  
 
AR aspecific ligands modulate the nAChR-channel openings 
In order to explore AR modulation of the biophysical properties of the embryonic nAChR 
channel, another set of experiments aimed at recording single channel openings in 
presence of the non-specific agonist NECA (100 M) and antagonist CGS 15943 (100 nM). 
Channel openings were recorded for at least 20 min in the absence of treatment (ctrl, 
autocrine channel activity) and for at least other 20 min after drug superfusion. To reduce 
membrane distortions introduced by seal formation in the cell attached configuration, 
which could interfere with second messenger effects, single channel activity was 
measured in different membrane patches before and after drug treatment, immediately 
after achieving the gigaseal.  
In all the cells tested, NECA increased the mean open time and the Po of channel openings 
(Control: mean open time, 7.24 ± 0.58 ms, n = 10; Po, 0.060 ± 0.014, n = 11; NECA: mean 
open time, 9.19 ± 0.43 ms; Po, 0.13 ± 0.017, n = 7; p < 0.01), whereas the antagonist CGS 
15943 significantly reduced the mean open time (5.03 ± 0.26 ms, n = 7; p < 0.001) without 
changing the Po (0.062 ± 0.016, n = 8; Fig. 4). In all the experiments, no change of ion 
channel conductance was observed (data not shown). 
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Fig. 4. Effect of the aspecific ARs modulation on nAChR biophysical properties. A. Effect of ARs 
modulation of nAChR activity in untreated conditions (Control) and in the presence of NECA 100 
µM or CGS 15943 100 nM. The ARs agonist NECA increased the mean open time and the channel 
Po, whereas the ARs inhibitor CGS decreased the mean open time without affecting the Po 
(statistical significance: ** p < 0,01 vs control). B. Representative traces of autocrine channels 
openings in ctrl conditions and in the presence of NECA and CGS. 
Results 
42 
Discussion 
 
Our data suggest that ARs activity controls nAChR-driven [Ca2+]i transients in 
differentiating myotubes. In fact, [Ca2+]i imaging revealed that the frequency of [Ca
2+]i 
spiking activity increased in the presence of NECA, while it was blocked in the presence of 
the antagonist CGS 15943. The inhibitory effect of adenosine deaminase (ADA) on [Ca2+]i 
spiking activity of twitching myotubes suggests the presence of endogenous adenosine in 
our conditions and that ARs are possibly tonically active, in agreement with the 
contraction-dependent release of adenosine reported in literature102,103.  
Taking into account what we have observed in the presence of the specific AR 
antagonists, even if still not conclusive, our results pointed out a prevalent role of A2BRs. 
A2Rs were previously proposed to modulate the nAChR channel properties via the 
intracellular cAMP signalling98. In this study, the authors demonstrated a negative 
adenosine-mediated regulation of nAChR activity. In contrast, our preliminary results 
indicate the existence of a potential positive feedback ARs-nAChRs. A possible 
explanation for this apparent discrepancy could be that Pitchford and coworkers have 
studied the adenosine effect not under basal conditions, but in the presence of a 
cholinergic agonist that increased significantly adenosine secretion and thus its 
endogenous content. 
In conclusion, our preliminary results are in favour of the role of adenosine in the 
regulation of the nAChR-dependent ([Ca2+]i) spikes during postnatal myogenesis. Further 
studies are required to better identify the contribution of each specific AR isoform on the 
biophysical properties of the nAChR single openings. Moreover, to better characterize the 
signalling mechanism between ARs-nAChRs, it would be of great interest to study the 
distribution of AR subtypes on differentiating myotubes and to identify which of the AR 
isoform co-localises with the nAChRs. 
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7. The “non-canonical” roles of neural agrin during myogenesis 
 
The heparan sulfate proteoglycan agrin was discoved almost 30 years ago, when 
McMahan and colleagues observed that components of the synaptic basal lamina carry 
instructive information necessary to induce pre- and postsynaptic specializations during 
neuromuscular regeneration104 105.  
Agrin is synthesized mainly by motor neurons, transported along motor axons and stably 
incorporated into the basal lamina of the synaptic cleft106,107, where it acts as a crucial 
organizer of neuromuscular junction. In fact, agrin deficient mutant mice die perinatally, 
due to respiratory failure as a consequence of a non-proper development of the NMJs 
throughout the body muscles108.  
The agrin gene encodes for a protein with more than 2000 amino acids, with a molecular 
weight of approximately 225 kDa, that can switch to higher values (up to 400-600 kDa). 
Indeed, the molecule owns numerous sites, like heparan sulfate and condroityn sulfate 
domains, that can be extensively O- and N-linked glycosylated109 (Fig. 8). The transcript of 
the agrin gene can be differentially spliced to produce different isoforms, each with its 
function and tissue distribution.  
Outside the skeletal muscle, this protein is broadly expressed in several other tissues, for 
instance in brain107, kidney110, heart111 and activated lymphocytes during immune 
response112. Its distribution indicates a wide range of effects of the molecule, most of 
which have been poorly investigated to date113.  
The agrin isoform synthesized and released by motor neurons, referred to as neural agrin, 
owns a N-terminal SS-NtA domain, through which it stably binds to the basal lamina of 
skeletal muscle cells. While the N-terminus of agrin is important to determine tissue 
distribution, the C-terminal half is the recognized “active” portion of the molecule. It 
comprises four epidermal growth factor-like domains (EG), three laminin G-like domains 
(LG1, LG2, LG3) and two additional splicing sites, known as A/y and B/z (A and B refer to 
the chick, y and z to mammals)114. The alternative splicing at this level produces agrin 
isoforms lacking or containing specific amino acidic inserts. The A/y domain is placed in 
the LG2 globule and can contain a sequence of 0 or 4 amino acids (Lys-Ser-Arg-Lys)114. 
Although the physiological role of the A/y insert is still not clear, it seems that it regulates 
agrin binding to heparin115. The B/z site is located in proximity of the LG3 domain, and it 
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can contain sequences of 0, 8, 11 or 19 amino acids. The inclusion of inserts at B/z site 
(B/z+ form) is of great importance for agrin activity at the NMJ116. This domain is 
considered the active site of the molecule in triggering the aggregation of AChRs, and for 
this reason neural agrin is also named as the “active isoform”114. 
 
 
Fig. 8. Agrin structure. At the N-terminus agrin can either display a SS-NtA domain (present in the 
neural form) or a transmembrane domain (TM). The NtA is required for binding to laminins, while 
the TM portion identifies agrin isoforms whose N-terminal is incorporated into the cell 
membrane. The central region is constituted by a rod-like structure, with several glycosilation and 
glycosaminoglycan (GAG) attachment sites. The C-terminal part of agrin owns three laminin-like 
domains (LG,) containing two splice sites, the A/y and the B/z. The four-amino acid insert at splice 
site A/Y binds to heparin, and the insert at B/z site is important to induce aggregation of AChR. 
The first two LG domains are involved in α-dystroglycan binding (modified from [113]). 
 
The key mediator of neural agrin signaling is the muscle-specific receptor tyrosine kinase, 
MuSK, expressed by the skeletal muscle fiber and concentrated at the post-synaptic 
region, where it co-localizes with the AChRs117 (Fig. 9 A). The receptor is a crucial player in 
NMJ formation. Knockout experiments demonstrated that the suppression of MuSK 
expression leads to a phenotype similar to that of agrin-deficient animals118. In addition, 
cells derived from MuSK-/- mice are incapable of aggregating AChRs in response to 
agrin119.  
MuSK is highly expressed by myotubes and skeletal muscle fibers and co-localizes with 
the AChRs at the NMJ120. It consists of an extracellular portion, with 4 immunoglobulin-
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like domains and a cysteine-rich domain; a transmembrane fragment (TM); an 
intracellular region with a juxtamembrane tyrosine (Y553), followed by a catalytic domain 
made up of 17 tyrosine residues117 (Fig. 9 B). MuSK phosphorylation does not occur 
following a direct agrin binding to the receptor119,121. Its activation is mediated by a co-
receptor, belonging to the low-density lipoprotein receptor family, LRP4122, capable of 
recognizing specifically the neuronal isoform of agrin121,122.  
 
 
Fig. 9. A. The receptor MuSK is expressed by skeletal muscle cells at the postsynaptic membrane 
of the NMJ, where it co-localizes with the AChRs. B. Schematic representation of MuSK structure: 
the receptor owns an extracellular N-terminal domain, a transmembrane region (TM) and an 
intracellular C-terminal domain that displays the kinase activity (modified from [117]).  
 
Binding of agrin to LRP4 stimulates MuSK dimerization and the consequent 
phosphorylation of specific intracellular sites. MuSK downstream pathway, leading to 
AChR clustering, constitutes a complex network of crosstalking signaling molecules123,124 
(Fig. 10).  
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Fig. 10. MuSK downstream pathway regulating the nAChR clustering. Agrin triggers MuSK 
dimerization with consequent phosphorylation of the intracellular tyrosine residues. Several 
effector proteins, such as Dok7 and Abl kinases, reciprocally interact with the receptor MuSK and 
contribute to the generation of the downstream signaling pathway. Actin remodeling drives AChR 
trafficking, insertion and immobilization and the aggregation of the AChR is stabilized by rapsyn 
(modified from [124]). 
 
In recent years, non-canonical roles of agrin have come to the fore, expanding its range of 
effects during myogenesis. These non canonical effects include remodelling of the muscle 
cell surface125 and cytoskeletal elements114, maturation of the excitation-contraction 
coupling mechanism126, modulation of the electrical properties127 and contractile 
function128.  
Considering that in mammals there seems to be a peculiar concentration of satellite cells 
in the proximity of the nerve terminals60, the mammalian myogenic precursors may be 
physiologically exposed to nerve-derived trophic factors like agrin.  
In this light we explored the effect of neural agrin on the control of functional properties 
of satellite cells. The research activity was aimed at investigating if neural agrin controlled 
the secretion of IL-6 and the proliferative capacity of the myogenic precursors. Our results 
revealed that IL-6 extracellular levels are increased following exposure to agrin (7.1. 
Appendix 3 – Published results) and that agrin could enhanced the proliferative capacity 
of human satellite cells (7.2. Appendix 4 – Preliminary results).  
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Abstract Proteins in living organisms have names that are
usually derived from their function in the biochemical system
their discoverer was investigating. Typical examples are acetyl-
cholinesterase and agrin; however, for both of these, various
other functions that are not related to the cholinergic system
have been revealed. Our investigations have been focused on
the alternative roles of acetylcholinesterase and agrin in the
processes of muscle development and regeneration. Previously,
we described a role for agrin in the development of excitability
in muscle contraction. In this study, we report the effects of
agrin on secretion of interleukin 6 in developing human muscle.
At the myoblast stage, agrin increases interleukin 6 secretion.
This effect seems to be general as it was observed in all of the
cell models analysed (human, mouse, cell lines). After fusion of
myoblasts into myotubes, the effects of agrin are no longer
evident, although agrin has further effects at the innervation
stage, at least in in vitro innervated human muscle. These
effects of agrin are another demonstration of its non-synaptic
roles that are apparently developmental-stage specific. Our data
support the view that acetylcholinesterase and agrin participate
in various processes during development of skeletal muscle.
Keywords Agrin . Acetylcholinesterase .Muscle cells .
Interleukin 6 . Neuromuscular junction
Introduction
Among the many proteins involved in development, assembly
and maintenance of neuromuscular junctions (NMJs) (Burden
2002), acetylcholinesterase (AChE) and neural agrin have
attracted great attention. Acetylcholinesterase (EC 3.1.1.7) is
anchored to the basal lamina of the NMJ, and it is responsible
for the termination of synaptic transmission (Rotundo 2003;
Massoulié and Millard 2009). Neural agrin is a trophic factor
that is released by nerve terminals (Nitkin et al. 1987), and it
has been identified as one of the crucial controllers of the
postsynaptic apparatus (McMahan 1990). This synaptic activ-
ity of neural agrin is based on its binding to the Lrp4/MuSK
receptor complex (Kim et al. 2008; Zhang et al. 2008;
Ghazanfari et al. 2011; Zong and Jin. 2013) and the related
signalling cascade that controls growth and stabilisation of
acetylcholine receptor (AChR) clusters and expression of
other important components of the postsynaptic membrane.
Although they have completely different synaptic roles,
AChE and neural agrin share numerous common features
(Mis et al. 2013). They are both expressed in both the neural
and muscle tissue of the NMJ, they are both expressed by a
single gene, followed by alternative splicing, and they both
have additional biological activities that are not directly linked
with the cholinergic system and synaptic transmission. In-
deed, it was shown that AChE controls cell adhesion, neurite
growth and network formation, embryonic development in the
central nervous system (Paraoanu et al. 2006), amyloid fibre
assembly in brain (Inestrosa et al. 2008), haematopoiesis
(Soreq et al. 1994), stress responses (Meshorer and Soreq
2006), apoptosis and inflammation (Pegan et al. 2010; Tsim
and Soreq 2012; Zhang and Greenberg 2012). The non-
synaptic effects of neural agrin include remodelling of the
muscle cell surface (Uhm et al. 2001) and cytoskeletal ele-
ments (Bezakova et al. 2001), maturation of the excitation–
contraction coupling mechanism (Bandi et al. 2008),
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modulation of the electrical properties (Jurdana et al. 2009)
and contractile function of developing skeletal muscle cells
(Bian and Bursac 2012).
In light of its non-synaptic roles, we have reported on the
influence of agrin in the development of skeletal muscle (Mis
et al. 2013). Here, we report the results of our recent investi-
gations that have focused on the role of neural agrin in the
control of cytokine signalling at the skeletal muscle level.
Skeletal muscle cells express and secrete interleukin 6 (IL-6)
and other cytokines, both constitutively (Prelovsek et al. 2006;
reviewed in Pedersen and Febbraio 2008) and in response to
various factors (Puppa et al. 2012; Podbregar et al. 2013). It is
generally accepted that secretion of IL-6 is a major cytokine
response in skeletal muscle to various environmental stimuli,
and that autocrine and paracrine effects of secreted IL-6 influ-
ence muscle development (Pedersen and Febbraio 2008).
Using an in vitro approach, we have here explored the
effects of neural agrin on IL-6 secretion at different
developmental stages in cultured skeletal muscle cells:
in the mouse C2C12 muscle cell line, and in primary
mouse and human muscle cells.
Material and Methods
The experiments on human muscle cells were approved by the
National Medical Ethics Committee of the Ministry of Health
of the Republic of Slovenia (permit numbers 63/01/99 and 71/
05/12) and were conducted in accordance with the Declaration
of Helsinki and Good Laboratory Practice regulations. Exper-
iments on mouse tissues were planned to use limited number
of animals and to minimise their suffering, and the procedures
were approved by the Veterinary Administration of the Min-
istry of Agriculture and the Environment of the Republic of
Slovenia (permit number 323-02-74/00).
Agrin Treatment
Recombinant full-length chick neural agrin (cAgrin7A4B8;
kindly provided by G. Fumagalli, University of Verona, Ve-
rona, Italy) was purified from conditioned media of stably
transfected HEK 293 cells using mono-Q-Sepharose fast-flow
beads (Amersham Pharmacia Biotech, Piscataway, NJ, USA),
as described previously (Bandi et al. 2008). In all of the cell
cultures, the agrin treatments were performed by replacing the
culture medium with medium supplemented with 1-nM
full-length neural agrin for 24 h, except in in vitro
innervated muscle cell cultures, where the cells were
treated with agrin for 3 days. The supernatants were
collected after these 24-h or 3-day treatments and frozen
at −80 °C until determination of IL-6 concentration. The
cells were fixed and stained for nuclei counting; using
Hoechst 33324 (see below).
IL-6 Detection
The levels of IL-6 secreted in the supernatants collected from
the cell cultures were measured using enzyme-linked immuno-
sorbent assay (ELISA) kits (Endogen, Rockford, USA), accord-
ing to the manufacturer instructions, and as described previous-
ly (Rezonja et al. 2013). To reach comparability of released IL-
6 from different cell cultures and between myoblasts and
myotubes, the amounts of IL-6 were calculated per 105 nuclei,
except in innervated muscle cultures, where the total amount of
IL-6 released into the culture medium was measured and used,
rather than calculated per number of nuclei. The numbers of the
nuclei were determined by Hoechst 33324 staining. Briefly, the
cells were fixed with 4% paraformaldehyde and incubated with
1 μg/ml Hoechst 33324 for 5 min at room temperature. The
counting of the nuclei was carried out for at least five optical
fields per well, and at least three wells were analysed for each
experimental point.
Calcium Imaging
Calcium imaging was used to check the presence of the
skeletal-type excitation–contraction coupling mechanism,
assessed as occurrence of an intracellular Ca2+ transient when
myotubes were depolarized with 40 mM KCl, in a Ca2+-free
solution (for further details, see Bandi et al. 2008). Briefly,
myotubes were loaded with the fluorescent Ca2+ indicator
fura-2 pentacetoxymethylester (5 μM) at room temperature
(30 min, in the dark). During Ca2+ measurements the temper-
ature was kept at 37 °C and cells were excited alternately at
340 and 380 nm. Fluorescence images were acquired by a
CCD camera (SensiCam; PCO Computer Optics, Kelheim,
Germany) at rate of 4 images/s. Calcium transients were
measured as variation in the mean value of the fluorescence
intensity in ratio images (340/380). The fluorescence at rest
was normalised to value 1. Variations in the intracellular
concentration of the ion were expressed as increase in fluo-
rescent signal relative to the fluorescence at rest.
Primary Human Muscle Cell Cultures
Primary human muscle cell cultures were derived from satellite
cells isolated from muscle tissue obtained from orthopaedic
surgery patients who had been previously diagnosed to be with-
out neuromuscular diseases. To release the satellite cells, the
human muscle tissue was separated from the connective tissue,
dissected into 0.5-mm to 1.0-mm pieces, and trypsinised. The
satellite cells were then grown to clonal density in 100-mm Petri
dishes in advanced Minimal Essential Medium (Invitrogen
Gibco, Paisley, UK) containing 10 % (v/v) foetal bovine serum
(FBS), at saturating humidity in a mixture of 5 % CO2 and air, at
37 °C. The myoblast colonies were further selected from the
fibroblast contaminants by morphological criteria.
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Myoblast cultures prepared from different donors were
checked prior their use for myogenicity by desmin counting,
and expanded in the advanced Minimal Essential Medium
with 10 % FBS, as described previously (Pegan et al. 2010;
Rezonja et al. 2013). The myoblasts were plated in six-well
dishes and cultured for 3 days before exposure to neural agrin.
To induce differentiation into myotubes, human myoblast
cultures plated in six-well dishes were shifted to differentia-
tion medium after 3 days (advanced Minimal Essential Medi-
um supplemented with 2 % FBS). After myoblast fusion, the
myotube cultures were maintained in differentiation medium
for an additional 10 days before neural agrin exposure.
To obtain innervated human myotubes, the myoblasts were
plated on glass coverslips coated with a 1:2 mixture of 1.5 %
gelatin (Sigma-Aldrich, St. Louis, MO, USA) and human
serum, in 35-mm six-well dishes. Subsequently, the myoblast
cultures were grown in F14 medium (Invitrogen) supplement-
ed with 10 % FBS, 50 ng/ml fibroblast growth factor, 10 ng/
ml epidermal growth factor, and 10 μg/ml insulin (all from
Sigma-Aldrich). After the myotubes formed from the myo-
blasts, up to four segments of dissected spinal cord explants
with preserved anatomical connections to dorsal root ganglia
and preserved meninges were placed onto the myotube mono-
layers. To isolate the embryonic spinal cords, timed pregnant
Wistar rats were sacrificed at 14 days from gestation in a CO2
chamber. Over the following 7–10 days, these explant co-
cultures were cultivated in F14 medium with 5 % (v /v ) FBS
and 10 μg/ml insulin, with this medium replaced with fresh
medium every 2 to 3 days. Functional innervation was
regularly monitored microscopically, as described in de-
tail previously (Mars et al. 2001; Rezonja et al. 2013).
Neural agrin exposure was carried out when functional
innervation (i.e., contraction-positive co-cultured ex-
plants) reached a steady-state.
Primary Mouse Muscle Cells
Primary mouse myoblasts were established from satellite cells
as described inmore detail elsewhere (Irintchev et al. 1997). The
mouse myoblasts were maintained in HAM’S F-10 medium
(ICN Biomedicals, Costa Mesa, CA, USA) containing 20 %
foetal calf serum (PAA Laboratories, Linz, Austria), 2 mM L-
glutamine, 100 units/ml penicillin and 100 μg/ml streptomycin
(all Sigma), for 1 day, before exposure to neural agrin.
To obtain mouse myotubes, 1 day after the myoblast plating,
the medium was replaced with Dulbecco’s modified Eagle’s
medium (ICN Biomedicals) supplemented with 2 % horse
serum (ICN Biomedicals), and L -glutamine, penicillin
and streptomycin, as above. The cells were maintained
at 37 °C in a mixture of 5 % CO2 and air. The
differentiation medium was renewed every 2 days. After
7 days in differentiation medium, the mouse myotubes
were treated with neural agrin.
C2C12 Muscle Cell Line
The mouse C2C12 muscle cell line was from Developmental
Studies Hybridoma Bank (Tacoma, Washington, USA). The
C2C12 myoblasts and myotube cultures were prepared and
grown using standard protocols, as described previously
(Gajsek et al. 2006). Treatment with neural agrin was carried
out with the same timing as that described for the primary
mouse myoblast and myotube cultures.
Statistical Analysis
All of the experimental data are expressed as means±S.D.,
and were obtained from three independent experiments with
multiple repeats for each experimental condition. Significance
was determined using Student’s t tests, with p <0.05 consid-
ered statistically significant. Univariate two-way analysis of
variance (ANOVA) was used to test for differences in IL-6
secretion in the control and agrin-treated cell cultures. Statis-
tical analysis was performed using IBM SPPS Statistics 20.0
for Windows (IBM Corp., Armonk, NY, USA).
Results
The Effects of Neural Agrin on IL-6 Secretion in Primary
Human Muscle Cell Cultures
The effects of neural agrin (1 nM, 24 h exposure) on the
secretion of the pro-inflammatory cytokine IL-6 was followed
at three differentiation stages of primary human muscle cell
cultures: myoblasts, myotubes, and in vitro innervated
myotubes. Human muscle cells aneurally grown or innervated
appeared highly differentiated morphologically (presence of
long multinucleated myotubes) and physiologically (presence
of skeletal-type excitation–contraction coupling mechanism
assessed by Ca2+ transients after depolarization in Ca2+ free
conditions) (Fig. 1a, b).
A significant 1.24-fold increase in constitutive IL-6 secre-
tion was detected in agrin-treated myoblasts when compared
with the control, untreated myoblasts (7.88±0.89 vs. 6.38±
0.79 ng IL-6/105 nuclei; p <0.05). After myoblast fusion into
myotubes, the IL-6 levels increased under both control condi-
tions and after exposure to neural agrin. The level of IL-6
released from the myotubes was significantly higher than in
the myoblasts under control conditions (1.59-fold; p <0.05).
After exposure of human myotubes to neural agrin, there was
a trend to an increase in the IL-6 content (1.06-fold), although
this effect of agrin was not statistically significant (10.77±
3.23 vs. 10.18±3.03 ng IL-6/105 nuclei) (Fig. 2). The IL-6
secretion was also evaluated in functionally innervated human
myotubes. At day 11 of culture with spinal cord explants, the
myotubes were treated with 1 nM agrin for 3 days. In the
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control co-cultures, the mean level of constitutive IL-6 secre-
tion was 24.64±11.47 μg/ml. In the agrin-treated co-cultures,
the IL-6 concentration was significantly higher, at 1.75-fold
the control (43.04±7.14 μg/ml; p <0.05) (Fig. 3).
The Effects of Agrin on IL-6 Secretion in Primary Cell
Cultures and C2C12 Mouse Muscle Cells
Primary and C2C12 mouse myoblasts and myotubes were treat-
ed with neural agrin at the same concentration as for the human
muscle cells (1 nM). As in human primary muscle cell model,
primary mouse and C2C12 myotubes appeared well differenti-
ated by morphological and physiological criteria (Fig. 1c, d).
Similar to our observations with the human muscle model, after
agrin treatment, there were significant increases in IL-6 secretion
in the primary muscle cells as well as in the C2C12 myoblasts.
These increases with respect to their corresponding controls
were 1.54-fold in agrin-treated primary myoblasts (9.98±1.71
vs. 6.48±0.18 ng IL-6/105 nuclei; p<0.05), and 1.16-fold in
agrin-treated C2C12 myoblasts (1.81±0.11 vs. 1.56±0.09 ng
IL-6/105 nuclei; p<0.05) (Fig. 4). In the myotube models of
both the primary cultures and the C2C12 cells, the exposure to
agrin did not significantly affect the constitutive secretion of IL-6
(primary: 13.04±1.80 vs. 9.88±0.80 ng IL-6/105 nuclei;
C2C12: 2.02±0.23 vs. 1.81±0.14 ng IL-6/105 nuclei), although
there were higher levels of constitutive IL-6 secretion in these
myotubes when compared to the myoblasts (Fig. 4).
Fig. 1 Differentiation in the cell models analysed. Primary human (a , b)
and mouse (c) muscle cell cultures, C2C12 muscle cell (d) are shown as
representative phase-contrast micrographs of differentiated myotubes
with corresponding Ca2+ transients elicited by depolarization in Ca2+-free
conditions, confirming the establishment of the functional skeletal-type
excitation–contraction coupling mechanism. Scale bars in phase-contrast
micrographs, 30 μm
Fig. 2 Secretion of IL-6 from control and agrin-treated humanmyoblasts
and myotubes. The primary human myoblasts and myotubes were treated
with 1 nM agrin for 24 h. The medium was then removed and IL-6
secretion was estimated by ELISA, with the amounts of IL-6 released
calculated per 105 nuclei. Data are means±SD, n indicates total number
of repeats analysed. *p <0.05 vs. control
Fig. 3 Secretion of IL-6 from the innervated control and agrin-treated
human muscle cell cultures. In the human myotubes co-cultured with rat
spinal cord explants, the treatment with neural agrin (1 nM, 3 days)
increased the constitutive secretion of IL-6. Data are means±SD, n
indicates total number of repeats analysed. *p<0.05 vs. control
J Mol Neurosci
Author's personal copy
Discussion
Here, we have demonstrated that at the myoblast stage of
muscle differentiation, neural agrin increases IL-6 secretion.
This effect was observed in all of the cell models analysed
here (human, mouse, cell lines). After the fusion of these
myoblasts into myotubes, this effect of neural agrin was not
evident any more, although neural agrin increased IL-6 secre-
tion again at the innervation stage, at least in this model of
innervated human muscle cells. This effect of agrin has not
been reported before, and it is another demonstration of the
non-synaptic roles of agrin, which appear to be diverse and
developmental-stage specific.
Interleukin 6 is a major muscle-derived cytokine that is
expressed and secreted from adult skeletal muscle under rest-
ing conditions (Pedersen and Febbraio 2008). During exercise
and in regenerating muscle, IL-6 secretion is markedly in-
creased (Kurek et al. 1996; Kami and Senba 1998). Addition-
ally, muscle progenitor cells, myoblasts and myotubes, con-
stitutively express and secrete IL-6 (De Rossi et al. 2000;
Prelovsek et al. 2006). The best known role for IL-6 is its
modulation of immune cell responses and regulation of energy
metabolism (Al-Khalili et al. 2006). Here, the IL-6 expression
and secretion in developing and regenerating muscle cells
indicates its additional role as a promoter of myoblast prolif-
eration, myotube formation, and induction of muscle hyper-
trophy (Austin et al. 1992; Serrano et al. 2008).
The regulation of IL-6 expression and secretion from mus-
cle precursor cells appears to be particularly complex and is
not yet completely understood, although it is known to be
affected by different factors and conditions. Tumour necrosis
factor (TNF)-α, IL-1, and lipopolysaccharide that are pro-
duced in activated immune cells and bacteria, and also endog-
enously, are known to modulate IL-6 secretion from muscle
cells (De Rossi et al. 2000; Prelovsek et al. 2006; Podbregar
et al. 2013). In addition to these factors, exposure of muscle
cells to glucocorticoids and hypoxia modulates IL-6 secretion
(Prelovsek et al. 2006; Pirkmajer et al. 2010). Our data in the
present study demonstrate that this cytokine signalling can
also be controlled by neurotrophic factors. Thus this enhanc-
ing effect of neural agrin on IL-6 secretion in human and
mouse primary muscle cell cultures, and also in the mouse
C2C12 muscle cell line, suggests that the control by this
neurotrophic factor is not a peculiarity of the human model,
which is well known as being more strictly dependent on
neural input (Gajsek et al. 2006; Tanaka et al. 2000).
In the present study, 1 nM neural agrin was used because of
previous reports showing that at such concentration the neu-
rotrophic factor has non-synaptic action (Bandi et al. 2008;
Mis et al. 2013). The effects here reported are to some extent
in agreement with the mechanisms underlying the role of agrin
in the formation of NMJs. These effects include the release of
agrin from the motor nerve endings, and its binding to and
activation of the MuSK tyrosine kinase receptor in the target
muscle cell (Glass et al. 1996). As a synaptic organiser, agrin
is known to induce AChR aggregation, although it also has
marked effects on gene expression in the synaptic nuclei,
which are mediated through a complex network of signalling
pathways (Bezakova and Ruegg 2003). The signalling path-
way that is most closely linked to IL-6 expression and secre-
tion is STAT3 signalling (Heinrich et al. 1998). However, at
present, there is no direct evidence that supports a link be-
tween agrin activation of the MuSK signalling pathway and
activation of the STAT3 signalling pathway.
Interestingly, the effects of agrin on IL-6 secretion appear
to be dependent on the stage of muscle cell differentiation,
with more pronounced effects in myoblasts and in innervated
muscle than in myotubes, where there was no significant
increase in IL-6 secretion upon treatment with agrin. This
observation is in agreement with previous reports where
TNF-α-, lipopolysaccharide- and glucocorticoid-dependent
IL-6 secretion was more pronounced in myoblasts than in
myotubes (Prelovsek et al. 2006). The different effects in
myoblasts, myotubes and innervated muscle cells might be
due to the well-known biological and phenotypical differences
between proliferatingmyoblasts, differentiated multinucleated
myotubes, and innervated and contracting myotubes, in terms
of protein expression and responses to different trophic and
extrinsic factors (Hauschka and Emerson 2004; Ciciliot and
Schiaffino 2010). In addition, this differentiation-dependent
agrin sensitivity might be due to differences in the ‘agrin
receptor’ complex in different cell types (Glass et al. 1996;
Bezakova and Ruegg 2003).
The non-synaptic role of agrin described here is in agree-
ment with the numerous other non-synaptic roles of agrin that
have been reported to date. Thus, agrin is an example of a
protein where the alternative splicing of a single gene can
produce isoforms with several different activities. A close
Fig. 4 Secretion of IL-6 from mouse primary muscle cells and C2C12
muscle cells. Treatment with neural agrin (1 nM, 24 h) increased IL-6
secretion in the primary and C2C12 mouse myoblasts, but did not signif-
icantly affect IL-6 secretion in the myotube models. Data are means±SD, n
indicates total number of repeats analysed. *p< 0.05 vs. control
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counterpart here is AChE, which is another protein that is
detected at the level of the NMJ that has more recently
discovered functions that are not related to the NMJ and the
cholinergic system (Mis et al. 2013). Different from their non-
synaptic (non-canonical) roles which seem to be separated,
AChE and agrin are interconnected in the processes of skeletal
muscle development and in their synaptic activities. AChE is
involved in myoblast apoptosis (Pegan et al. 2010), while
agrin is involved in control of excitation–contraction coupling
mechanism (Bandi et al. 2008) and contractile apparatus mat-
uration (Mis et al. 2013). Treatment with agrin results not only
in aggregation of existing AChR into clusters (Tsim and
Barnard 2002) but also in a rapid translocation of receptors
to the AChE clusters (Rotundo et al. 2005). Synaptic trans-
mission organized through synaptogenetic actions of agrin
induces AChE appearance at the NMJ (Sanes et al. 1998).
Accumulation of AChE in dense patches which is a part of
NMJ formation (Grubic et al. 1995; Siow et al. 2002; De Jaco
et al. 2005; Camp et al. 2008; Tsim et al. 2010) is also induced
by agrin. However, synaptogenetic actions of agrin can be
modulated by AChE as shown by Choi et al. (1998) where
over-expression of AChE promotes postsynaptic specializa-
tion through stimulation of agrin expression.
In conclusion, the present study reveals another non-
canonical function of neural agrin, which supports the view
that as well as having a role in NMJ assembly and cholinergic
transmission, this neurotrophic factor participates in various
other processes that take place during differentiation of skel-
etal muscle. Our observations provide new insights into the
involvement of neural agrin, and more in general of neuro-
trophic factors, in the control of skeletal muscle plasticity and
regeneration.
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Neural agrin positively affects the proliferation of old donor-derived 
human myoblasts 
 
 
Introduction 
As already mentioned in the general introduction, aging of the skeletal muscle is 
characterized by a severe reduction in tissue mass, strength and endurance. The impaired 
regenerative response of satellite cells during aging is widely accepted but the molecular 
causes underlying this phenomenon are still partially unclear. Among the possible 
reasons, changes in the composition of the systemic and/or local environment may be 
responsible for satellite cell diminished regenerative ability. The influence of the external 
milieu was demonstrated by transplanting experiments of old muscles into young 
animals, where satellite cell regeneration was successfully restored74. 
Beside local chemical signals released by satellite cells, myofibers, and neighbouring non-
muscle cells11,76, nerve-derived factors may have a an important impact in regulating 
satellite cells behaviour and their level are possibly reduced during aging. In fact, aging of 
the skeletal muscle is characterized by an extensive loss of motor neuron contacts. Even if 
the contribution of nerve-derived factors has not been extensively characterised, it is 
known that denervation contributes to the progression of sarcopenia, leading to abortive 
myogenesis129 and loss of muscle mass68,130. The magnitude of denervation is much higher 
in human muscle, as compared to rat muscles, suggesting that humans are more 
susceptible to age-related denervation and atrophy131,132. Among nerved-derived trophic 
factors whose levels are possibly reduced as a consequence of age-related denervation, 
neural agrin is a promising candidate. Very recently, an elevated agrin degradation has 
been demonstrated in a large subpopulation of sarcopenic human patients, suggesting a 
role for agrin in the pathogenesis of sarcopenia133. 
In the light of this evidence, and of others indicating agrin as a key factor controlling 
proliferation/survival134, the specific aim of the present research activity was to explore 
the possible role of neural agrin as controller of human satellite cell proliferation.  
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Methods 
Isolation and purification of human skeletal myoblasts 
Experiments were approved by the Ethics Commission at the Ministry of Health of the 
Republic of Slovenia or by the Ethics Commission of the Medical Faculty of the University 
of Bonn. Primary human myoblast cultures were prepared from skeletal muscle tissue 
discarded during routine orthopaedic operations. Donors or their parents (legal 
representatives) signed an informed consent agreeing that the skeletal muscle tissue 
could be used for experimental purposes. None of the donors had neuromuscular 
disease. Cell cultures were prepared as described elsewhere in more detail126,135,136. 
Briefly, skeletal muscle tissue was cleaned of visible connective and adipose tissue and 
then cut into small (0.5-1 mm) pieces under the microscope. This was followed by 
trypsinization (0.15%; 37 °C for 30-45 min) in Earle's Balanced Salt Solution (EBSS) to 
digest basal lamina and release the satellite cells. The cell suspension was then 
centrifuged (1000 rpm; for 5 min), pellet was resuspended and cells were plated into cell 
culture dishes. Primary human skeletal muscle cells were grown, at 37 °C in humidified 
atmosphere (95% air/5% CO2), in Advanced MEM, supplemented with 10% (v/v) FBS, 
0.3% (v/v) fungizone and 0.15% (v/v) gentamicin. Three-week old primary cultures were 
trypsinized and then purified using MACS CD56 microbeads (Miltenyi Biotec, Bergisch 
Gladbach, Germany) in order to separate the myoblasts from other cell types (mainly 
fibroblasts) contaminating the primary culture. After purification and desmin staining (see 
below), myoblasts were used for experiments or frozen in liquid nitrogen until further 
use.  
 
Old and young donor-derived myoblasts 
Primary myoblast cultures were prepared from skeletal muscle samples collected from 
two groups of donors. The first group consisted of donors whose age ranged from 5 to 15 
years (young myoblasts), the second of donors ranging from 50 to 80 years of age (old 
myoblasts). Before their use, the percentage of myogenic cells was assessed by desmin 
staining. Cell cultures with a desmin counting higher than 75% were selected for the 
experiments here described.  
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C2C12 cell culture 
Mouse C2C12 myoblasts (Developmental Studies Hybridoma Bank, Tacoma, Washington) 
were cultivated in proliferative conditions, using Dulbecco’s modified Eagle’s medium 
(DMEM), supplemented with 20% (v/v) FBS, 4 mM L-glutamine, 100 IU mL-1 penicillin and 
100 μg mL-1 streptomycin. Each time that cells reached 75% confluence, they were 
trypsinized and replated. Cells were maintained at 37 °C in an atmosphere humified 100% 
(95% air/5% CO2).  
 
Growth curves and cumulative number of population doublings 
The proliferative capacity of myoblasts from different donors was assessed by estimating 
their growth curves and cumulative number of population doublings (CPD) over the entire 
course of the in vitro lifespan. The two parameters were evaluated in growth medium 
(GM) or in GM supplented with 1 nM full-length neural agrin. GM consisted of Ham’s F10 
supplemented with FBS (20%; Euroclone, Pero, Italy), 1 mM L-glutamine, 100 units mL-1 
penicillin and 100 g mL-1 streptomycin. In the two experimental paradigms, human 
myoblasts were plated at the same density (14 cells/mm2). Control and agrin-treated 
myoblasts were both expanded until the sub-confluent state and counted using a Coulter 
counter. At each cell passage, the mean population doubling (MPD) was calculated as 
MPD = LogN/Log2, where N is the number of cells harvested divided by the number of 
cells seeded. For each experimental point, at least three different dishes were analysed; 
for each cell sample, cell number was determined in duplicate. Cell cultures were 
considered at the end of their in vitro lifespan (senescence), when their number remained 
constant during two consecutive sub-cultures. Myogenicity was routinely checked by 
immunocytochemistry for desmin (see below). GM was changed every 3 days. 
 
BrdU proliferation assay 
Bromodeoxyuridine (BrdU) Cell Proliferation Assay Kit was used to estimate the rate of 
myoblast proliferation. Human myoblasts were plated in 96-well plates in GM at the 
density of 50 cells/mm2. The day after seeding, myoblasts were exposed to neural or 
mini-agrin and/or imatinib or PD185352 for 24, 48 or 72 h. Myoblasts were then 
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incubated with BrdU for additional 16 h. Samples were prepared for BrdU absorbance 
measurement according to the manufacturer’s protocol. Absorbance was measured at 
dual wavelengths (450 and 550 nm) using Victor 3 plate reader (PerkinElmer, Shelton, 
Connecticut, USA). Results were expressed as the difference between absorbance at 450 
nm and 550 nm or as percent-control. Each independent experiment was done in at least 
4-8 replicates for each treatment.    
 
Western Blot 
Human myoblasts were washed with ice-cold PBS and then harvested with lysis buffer 
(1% (v/v) Protease Inhibitor Cocktail, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 0.5 mM 
Na3VO4, 1% (v/v) Triton X-100, 1% (v/v) glycerol, 20 mM Tris, 10 mM NaF, 1 mM EDTA, 
and 1 mM phenylmethanesulfonyl fluoride). Lysates were centrifuged at 4 °C (12000 g, 15 
min) and supernatants were collected. Total protein concentration was measured with 
Bicinchoninic Acid (BCA) Protein Assay Kit. For SDS-PAGE, collected supernatants were 
diluted to the same final protein concentration and incubated in Laemmli buffer (62.5 
mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% (w/v) glycerol, 0.002% (w/v) bromophenol blue, 
5% (v/v) β-mercaptoethanol) for 20 min at 56 °C. Protein samples were separated on 4-
12% Bis-Tris gel and transferred to PVDF membrane using Criterion system (Bio-Rad, 
Hercules, California, USA). To assess sample loading and the efficiency of the transfer, 
membranes were stained with 0.1% (w/v) Ponceau S in 5% (v/v) acetic acid. Membranes 
were blocked in 7.5% (w/v) non-fat milk in TBS-T (10 mM Tris, 137 mM NaCl, 0.02% (v/v) 
Tween-20, pH 7.6) and subsequently probed with primary antibodies against MuSK or 
total Abl overnight at 4 °C. GAPDH was used as loading control. Following overnight 
incubation, membranes were incubated with the appropriate HRP-conjugated secondary 
antibody. Immunoreactive proteins were visualized using enhanced chemiluminescence 
and analysed with Chemigenius Bio-imaging System (Syngen, Cambridge, UK). 
 
Myoblast fusion efficiency 
To estimate the efficiency of myotube formation, fusion index and the mean number of 
nuclei/myotube were determined. To trigger cell differentiation and fusion into 
myotubes, myoblasts were plated on matrigel-coated coverslips at 150 cells/mm2 in GM 
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and, three days after plating, GM was substituted with differentiation medium (DM: 
DMEM supplemented with 2% FBS, 100 μg mL-1 apo-transferrin, 10 μg mL-1 insulin, 4 mM 
L-glutamine, 100 units mL-1 penicillin and 100 g mL-1 streptomycin). Fusion index and the 
mean number of nuclei/myotube were quantified on the 7-12th day of differentiation (i.e. 
days in DM). These parameters were determined in five randomly chosen optical fields 
per coverslip. Fusion index was expressed as the number of nuclei in myotubes divided by 
the total number of nuclei. Myotubes were defined as cells having more than two nuclei.  
 
Ca2+ imaging in cultured myotubes 
Ca2+ imaging experiments were carried out to check the presence of the skeletal-type 
excitation-contraction coupling mechanism, assessed as the cell capability to generate an 
intracellular Ca2+ transient when depolarized (60 mM KCl) in Ca2+-free solution (140 mM 
NaCl, 2.8 mM KCl, 2 mM EGTA, 5 mM MgCl2, 10 mM glucose, 10 mM Hepes; pH 7.3). To 
this purpose, cells were seeded and differentiated (7-12 days) on glass coverslips coated 
with matrigel. For Ca2+ measurements see the detailed protocol described by 
Sciancalepore and collaborator in Appendix 399. For each experimental point at least 6 
coverslips were analysed. For each coverslip, a random field with 3-10 myotubes was 
chosen. 
 
Desmin staining 
Desmin is an intermediate filament, which is widely used as a marker for cells of 
myogenic lineage160. For desmin staining assessment, human cells were plated onto 
matrigel-coated glass coverslips. Before staining, cells were fixed in 4% (w/v) 
paraformaldehyde, permeabilized with 0.5% Triton X-100 (5 min, room temperature). 
Then, they were incubated with primary anti-desmin antibody (1:50 in PBS; overnight at 4 
°C) and with rhodamine-conjugated secondary antibody (1:200 in PBS; 1 h at room 
temperature). Cells were also stained for nuclei with Hoechst-33258 (1 μg mL-1). Images 
were taken with a fluorescent microscope (Nikon Eclipse E800,Tokyo, Japan.) at 590 nm 
for desmin and at 461 nm for Hoechst-stained nuclei. The percentage of myogenic cells 
was estimated as the number of desmin-positive cells divided by the number of Hoechst-
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stained nuclei. At least five randomly chosen optical fields in three different coverslips 
were determined.  
 
Recombinant neural agrin purification 
Recombinant full-length chick neural agrin (cAgrin7A4B8) was purified from the conditioned 
media of stably transfected HEK-293 cells (kindly provided by G. Fumagalli, University of 
Verona, Verona, Italy) using mono Q-Sepharose fast flow beads (Amersham Pharmacia 
Biotech, Piscataway, New Jersey, USA), as previously described126,137.  
 
Chemicals, reagents and materials 
Cell culture media and reagents were from Invitrogen (Life Technologies, Paisley, UK) and 
cell culture materials were from Greiner (Greiner Bio-One GmbH, Germany), unless 
otherwise specified. Matrigel was from BD Biosciences (Bedford, Massachusetts, USA). 
BrdU Proliferation Assay Kit was obtained from Calbiochem (KGaA, Darmstadt, Germany). 
MES running buffer, 4-12% bis-Tris gels were obtained from Bio-Rad (Hercules, California, 
USA). Reagents for enhanced chemiluminescence (ECL) and BCA Protein Assay kit were 
from Thermo-Scientific Pierce (Rockford, Illinois, USA). Protein molecular weight marker 
(full range rainbow marker) was purchased from GE Healthcare (Uppsala, Sweden). PVDF 
membrane was from Millipore (Billerica, Massachusetts, USA). Agfa X-Ray films (Agfa, 
Zagreb, Croatia) were developed using Curix 60 developing machine (AGFA HealthCare, 
Greenville, South Carolina, USA). RNeasy Mini Plus kit was from Qiagen (Hilden, 
Germany).  
Recombinant C-terminal fragment of rat agrin (550-AG; mini-agrin) was purchased from 
R&D Systems (Minneapolis, MN, USA). Abl kinase inhibitor imatinib (STI571; Gleevec ) 
was kindly provided by Novartis (Varese, Italy) and MEK1/2 inhibitor PD185352 was from 
Sigma-Aldrich. 
 
Antibodies 
Antibody against N-terminal of human MuSK was from R&D Systems (Minneapolis, 
Minnesota, USA). Antibodies against total Abl and GAPDH were from Cell Signaling 
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Technology (Beverly, Massachusetts, USA). Anti-rabbit and anti-goat horseradish 
peroxidase (HRP)-conjugated secondary antibodies were from Bio-Rad (Hercules, 
California, USA) and Thermo Scientific Pierce (Rockford, Illinois, USA), respectively. Goat 
anti-desmin antibody, used for cytochemistry, was from DakoCytomation (Glostrup, 
Denmark). Rhodamine-conjugated secondary antibody was from Jackson 
ImmunoResearch Laboratories Inc. (West Grove, Pennsylvania, USA).  
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism 4.0 Software. ANOVA, followed 
by Bonferroni’s post hoc test, were used to evaluate the differences among several 
groups. Unpaired Student t-test was used when only two groups were compared. Results 
are expressed as means ± SEM. Statistical significance was established at p < 0.05.  
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Results 
Neural agrin increases the cumulative number of population doublings of myoblasts 
derived from old donors  
Growth curves and cumulative number of population doublings (CPD) were evaluated 
culturing human myoblasts (HM) in presence or absence of 1 nM recombinant full-length 
neural agrin, until they reached senescence (see Experimental procedures). Experiments 
were performed on cells isolated from three old donors (“old myoblasts”) and two young 
donors (“young myoblasts”). Two growth curves representative of old and young 
myoblasts are shown in Fig. 1A.  
 
Fig. 1. Neural agrin promotes proliferation and stimulates BrdU incorporation of human myoblasts 
derived from old donors. A. The two graphs show two representative growth curves for old and 
young group of myoblasts, in the presence of 1 nM neural agrin or in control conditions. In old 
myoblasts, neural agrin increased the cumulative number of population doublings by ~ 30% (see 
also Table 1), while the neurotrophic factor did not affect the growth curve in the young. Results 
are means ± SEM. Statistical differences: **p < 0.01, ***p < 0.001 vs Control. B. The graph shows 
BrdU absorbance values in control condition and after 24-h treatment with 1 nM neural agrin in 
three old and three young myoblast populations. Results are mean absorbance values ± SEM. 
Statistical significance: *p < 0.05, **p < 0.01 vs Control. 
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Notably, 1 nM neural agrin elevated the CPD of old myoblasts already after 2-4 replicative 
cell cycles and its effect was maintained throughout the in vitro lifespan, including the 
plateau phase. In old and young cell populations, the desmin counting was regularly 
carried out from the early up to the late passages, when cells approached the cell cycle 
arrest and ceased to divide. The fraction of desmin-positive cells remained unaltered in 
agrin-treated cells as well as in control counterparts, indicating that cell myogenicity was 
not decreased during agrin treatment (data not shown). 
Overall, agrin elevated the cumulative number of cell doublings (CPD) of myoblasts from 
old donors by ~ 15 – 45% (Table 1). Conversely, the CPD of myoblasts from young donors 
remained unaltered even during exposure to lower (100 pM) or higher (50 nM) agrin 
concentrations (data not shown), excluding the possibility of a dose-dependent effect.  
 
 
 
 
 
 
 
 
Table 1. Age-dependent effect of neural agrin on 
the CPD of human myoblasts. n = number of Petri 
dishes; statistical significance: ** p < 0.01; *** p < 
0.001  
 
We also measured BrdU incorporation. Myoblasts derived from three different old and 
young donors were grown in the presence or absence of 1 nM neural agrin for 24 h. Agrin 
exposure increased BrdU incorporation in all the three populations of old myoblasts. 
 
 
    Cumulative number  
of population doublings (CPD) 
Age of donor 
(years) 
Control 1 nM neural 
agrin 
58 9.95  0.32 
(n = 4) 
13.07  .14*** 
(n = 4) 
60 4.24  0.09 
(n = 4) 
4.83  0.08** 
(n = 4) 
66 1.63  0.02 
(n = 5) 
2.38  0.09*** 
(n = 5) 
5 12.21  0.09 
(n = 4) 
12.33  0.07 
(n = 4) 
7 22.70  0.15 
(n = 3) 
22.28  0.08 
(n = 3) 
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Conversely, BrdU incorporation remained unaltered in young myoblasts (Fig. 1B). Thus, 
the results indicated an age-dependent effect of agrin on myoblast proliferation. 
 
Mini-agrin stimulates BrdU incorporation in old myoblasts 
The C-terminal part of agrin is necessary as well as sufficient for the binding to MuSK and 
α-dystroglycan and for its well-known effect on AChR clustering138. To examine whether 
the effect of agrin resided in this portion of the molecule, BrdU incorporation was 
evaluated in old myoblasts exposed for 24 and 72 h to 1 nM full-length or mini-agrin, 
consisting of the C-terminal half of the molecule (see Experimental procedures). BrdU 
incorporation, expressed as percentage in respect to control, was respectively 19.00 ± 
5.57% (n = 7 wells) vs 25.20 ± 4.99% (n = 8) at 24 h and 69.80 ± 9.66% (n = 8) vs 71.20 ± 
3.12% (n = 8) at 72 h (Fig. 2). Therefore, mini-agrin mimicked the full-length agrin effect at 
both the time points considered.  
 
 
Fig. 2. Mini-agrin mimics the effects of full-length neural agrin in old human myoblasts. (A) 
Cultured myoblasts from an old donor aged 77 years where exposed to 24 or 72 h treatment with 
1 nM mini-agrin. The miniaturized form of neural agrin increased the BrdU incorporation as well 
as the full-length molecule. Results are mean ± SEM. Statistical significance: *p < 0.05, **p < 0.01, 
***p < 0.001 vs Control. 
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MuSK is expressed in old and young human myoblasts 
MuSK is an essential part of the agrin receptor complex in myotubes117,119. To determine 
whether MuSK is expressed in human myoblasts, whole-cell lysates were blotted for 
MuSK, using human and C2C12 myotubes as positive controls120.  
Western blotting revealed bands of appropriate molecular masses indicating the presence 
of MuSK receptor in human myoblasts as well as in human and C2C12 myotubes (Fig. 3). 
Antibody against N-terminal of human MuSK detected two immunoreactive bands 
between 76 and 100 kDa, in accordance to previous reports139. The bands were 
appreciable in myoblasts derived from old as well as young donors. 
 
 
Fig. 3. MuSK and Abl are expressed in old human myoblasts derived from old donors 
Representative Western Blot for MuSK and total Abl in human myoblasts and myotubes and 
C2C12 myotubes. Bands marked with Mb and Mt were from myoblasts and myotubes 
respectively. Human cells were from a 65 year-old donor. GAPDH was used as a loading control.  
 
Inhibition of Abl downstream of MuSK prevents the effect of neural agrin in old 
myoblasts   
Abl is a well-known effector of MuSK and contributes to agrin-induced AChR clustering in 
differentiating myotubes and adults skeletal muscle fibres140. More recently, it has been 
also reported the role of Abl kinase as regulator of muscle cell proliferation141. Therefore, 
we explored whether agrin required Abl activity to stimulate old myoblast proliferation.  
We first assessed the presence of Abl kinase in old myoblasts. Western blotting detected 
Abl kinase band in old myoblasts, as well as in human and C2C12 myotubes (positive 
control; Fig. 3).  
In a second set of experiments, myoblasts derived from old donors were exposed to a 
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specific Abl kinase inhibitor, Imatinib (STI571, Gleevec®)142.  
A set of control experiments was carried out to check the effect of imatinib applied alone. 
A 48-h incubation with 1 M imatinib slightly decreased the BrdU incorporation (95.60 ± 
9.23%; n = 3 wells), however the effect was not statistically significant. At 10 M imatinib, 
the percentage decreased to 70.73 ± 6.00% (n = 6), with a reduction of ~ 30% with respect 
to untreated cells (Fig. 4). Apparently, no toxic effect observed in imatinib-treated cells at 
the two concentrations (data not shown). 
In HM66 treated with 1 nM neural agrin (48 h), the Abl inhibitor prevented the agrin-
effect at both concentrations, indicating that Abl activity mediated the effect of agrin on 
old myoblast proliferation. When co-administered at 1 µM and 10 µM, the percentages of 
BrdU incorporation were significantly lower than in cells exposed to agrin alone: 
respectively 107.40 ± 20.44% (n = 3) and 63.43 ± 6.02% (n = 3; Fig. 4). 
 
 
Fig. 4. Neural agrin depends on Abl to promote old myoblast proliferation. 1 and 10 M imatinib 
was used to block the activity of Abl kinase. When applied alone, imatinib significantly decreased 
the BrdU incorporation at 10 M. When 1 and 10 M imatinib were co-administered with neural 
agrin, the BrdU incorporation was significantly diminished in respect to agrin-treated cells. Results 
are mean ± SEM. Statistical significance: *p < 0.05 vs Control. #p < 0.05 vs agrin-treated cells. 
 
Agrin depends on ERK1/2 to stimulate myoblasts proliferation 
We next investigated whether suppression of ERK1/2 was involved in the proliferative 
effects of agrin. To do this, we used PD185352, a MEK1 kinase inhibitor preventing 
ERK1/2 activation. We determined BrdU incorporation in old human myoblasts treated 
with 1 μM PD185352 in the absence or presence of 1 nM agrin. Cultured myoblasts were 
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exposed to these treatments for 24 or 48 h prior to BrdU assay. As shown in Fig. 5, 
PD185352 alone reduced basal BrdU incorporation by 60% (respectively for 24 and 48h: 
38,59 ± 6,94%, n = 6 wells p < 0.001 and 43,75 ± 9,95, n = 6, p < 0.001) and completely 
prevented agrin-stimulated increase in BrdU incorporation in old myoblasts (respectively 
for 24 and 48h: 39,52 ± 4,51%, n = 6 wells and 33,91 ± 2,41%, n = 6). Taken together, 
these data suggest that inhibition of ERK1/2 blocks agrin-stimulated proliferation of old 
myoblasts.  
 
 
Fig. 5. Neural agrin depends on ERK1/2 to promote myoblast proliferation. Human myoblasts 
derived from a 66 years old donor were exposed to 1 μM PD185352 in the absence or presence of 
1 nM agrin for 24 or 48 hours prior to BrdU assay. Results are means ± SEM. Statistical 
significance: **p <0.01, *** p <0.001 vs Control; ### p <0.001 vs neural agrin. 
 
Exposure to neural agrin does not impair the differentiation efficiency of old human 
myoblasts 
We also checked whether agrin-treated old myoblasts maintain capability to differentiate 
despite the enhanced proliferation. To this end old myoblasts were treated with 1 nM 
neural agrin in proliferative phase and were then analysed for their ability to fuse into 
myotubes and to establish the skeletal-type excitation-contraction (e-c) coupling 
mechanism, based on the mechanical link between L-type voltage-operated Ca2+ channels 
and ryanodine receptors143,144.  
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To induce cell differentiation, myoblasts were cultivated in low serum conditions for 10 
days (see Experimental procedures for further details). Cell fusion efficiency was analysed 
evaluating fusion index and number of nuclei/myotube. The presence of the e-c coupling 
mechanism was assessed by a conventional protocol of stimulation using Ca2+ imaging145, 
i.e. measuring the number of cells in which a Ca2+ transient was elicited by depolarisation 
(60 mM KCl) in Ca2+-free conditions (2 mM EGTA excess). 
The fusion index and the number of nuclei/myotube were similar to control cells (Fig. 6A). 
The fusion index was 66.20 ± 5.40% (n = 5 optical fields) in differentiated cells derived 
from agrin-treated myoblasts 58.60 ± 9.60% (n = 5) and in control cells. The number of 
nuclei/myotube was 7.86 ± 1.10%, (n = 28 myotubes) vs 6.12 ± 1.09% (n = 16) respectively 
(Fig. 6A).  
The percentage of cells exhibiting a skeletal-type e-c coupling mechanism was higher in 
myotubes derived from agrin-treated myoblasts than in controls (Fig. 6B). The 
percentages of coupled cells were 87.50 ± 12.50% (n = 4 optical fields) vs 58.33 ± 7.45% (n 
= 5). The difference between the latter two values, although not statistically significant (p 
= 0.07), highlights a trend of increase in the number of coupled myotubes derived from 
agrin-treated myoblasts with respect to untreated cells.  
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Fig. 6. Neural agrin does not impair cell fusion and functional differentiation of old donor-derived 
human myoblasts. A. Fusion index (%) and mean number of nuclei/myotube in human myotubes 
derived from agrin-treated and untreated cell derived from a 66-year-old donor. The treatment 
with neural agrin in the proliferative phase did not impair the ability of cells to form myotubes. B. 
Left, a representative Ca2+ response to 60 mM KCl in Ca2+-free conditions measured in a coupled 
cell. Right, a histogram showing the number of responsive myotubes (coupled cells).  
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Discussion 
 
The main finding of this study is that neural agrin, a nerve derived factor, boosts the in 
vitro proliferative performance of human myoblasts from elderly subjects. Our results 
confirm the emerging hypothesis that local chemical signals play an important role in 
rendering the satellite cell niche a permissive environment for an efficient regenerative 
activity. Furthermore, they shed some new light on the nerve-release molecules 
contributing to the regenerative potential of skeletal muscle precursors.  
The proliferative potential of myoblasts isolated from old and young donors have been 
compared: i) in the same cell culture conditions (20% of FCS) and ii) in cell populations 
with a comparable (higher than 75%) and stable number of desmin positive cells. This was 
made to exclude any possible contribution of different content of trophic factors, present 
in the serum essential for cell expansion, and/or possible change in the proportion of 
myoblasts vs fibroblasts or other cell contaminants146 in the determination of CPDs in the 
different cell populations. In absence of neural agrin, all the myoblast populations from 
old subjects exhibited a significantly lower proliferative capacity, according to very recent 
reports showing that this occurred when human myoblasts are cultivated in conditions 
more similar to the physiological environment in vivo71. Chronic cell exposure to neural 
agrin induced a significant increase in the CPDs limited to the old-derived myoblasts. The 
experiments of BrdU incorporation indicated that such effect was due to an enhancement 
of the proliferative potential, although our experiments cannot exclude a possible 
concomitant inhibition of cell death. Further experiments investigating this intringuing 
potential effect of neural agrin would merit specific investigations.  
Interestingly, the treatment of old myoblasts with a miniaturized form of the molecule, 
called mini-agrin, mimicked the effect of the full-length molecule on BrdU incorporation. 
Our results indicate that the effect of neural agrin on myoblast proliferation resided in the 
same portion of the molecule responsible for the canonical biological effects of the neural 
trophic factor on AChR aggregation. In fact, the mini-agrin we used, consists of the C-
terminal half of the molecule, containing a splicing insert at site z (9 aa), and the laminin 
G-like domains 1, 2 and 3, accountable for the binding to MuSK138. In the light of this 
observation, it was subsequently explored the expression of MuSK. By western blotting 
old human myoblast samples we were able to detect the receptor. However, the bands 
Results 
65 
were very weak, while its expression was potentiated following myoblast fusion and 
myotube formation. This is in agreement with published data reporting low levels of 
expression for cycling rodent myoblasts and up-regulation of the receptor during 
differentiation120. Taking into account that mini agrin owns also the binding site for α-
dystroglycan, we cannot exclude their possible contribution to the control of cell 
proliferation. Similarly to MuSK, α-dystroglycan role is documented in mature 
differentiating skeletal muscle cells147, while less is known about its function in myoblasts. 
Western blotting confirmed the presence of Abl in old myoblast samples. The blocker of 
Abl imatinib (10 M) administered alone reduced the BrdU incorporation in aged 
myoblast. Analysis of cell survival (data not shown), excluded any toxic effect of the drug. 
Instead, such an effect indicated that Abl played a role in the regulation of cell 
proliferation in old skeletal myoblasts. As suggested, imatinib could interfere with bFGF 
and HGF present in the serum-containing medium necessarily used to maintain myoblasts 
in the proliferative phase148. For this reason imatinib effect on cell proliferation was 
assessed also at a lower concentration (1 M), supposed not to inhibit bFGF- and HGF-
dependent cell proliferation148. In this condition, imatinib still prevented neural agrin 
effect on BrdU incorporation, indicating that the action of the trophic factor requires Abl 
signalling. This evidence underlines once again that, besides its synaptogenic function, 
neural agrin is involved in other cell processes at the muscle level and confirms its 
pleiotropic role. If on the one hand agrin signalling could regulate the proliferation in 
cycling myoblasts, on the other, after the cell cycle arrest, its function could switch to the 
control of the neuromuscular junction formation/stabilization and the maturation of 
other cell functional properties126-128,149.  
As already mentioned, the effect of neural agrin on proliferation was limited to the 
myoblasts populations isolated from old donors. However, Abl proteins and the inhibitory 
effect of imatinib on cell proliferation were detected also in myoblasts from young 
subjects (data not shown) indicating that the Abl signalling contributes to cell cycling also 
in the young cells. One possible explanation for the exclusive effect of neural agrin in old 
myoblasts could be that the proliferative rate of young myoblasts are intrinsically high 
and cannot be significantly enhanced by the neurotrophic factor, while its effect could 
become appreciable in cells where the proliferative potential is reduced. In line with this 
interpretation, we observed that the enhancing effect of neural agrin on CPDs varied 
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from 15 to 45% in old myoblasts and the lower was myoblast proliferative capacity in the 
absence of the trophic factor, the higher was agrin enhancing effect (see Table 1). 
Accumulating evidence indicates that mitogenic signals often depend on the activation of 
the ERK pathway150. The results of ERK inhibition through the PD185352 compound 
indicate that this MAP kinase could contribute to agrin-induced modulation of cell 
proliferation. The extent of inhibition of cell proliferation in the presence of PD185352 
was considerably high. This fact suggests a possible interference with other signalling 
pathways controlling cell cycling. Also for this reason, these results have to be considered 
only preliminary and new functional data on agrin-dependent ERK activation are needed.  
The very last observation was that aged myoblasts chronically exposed to neural agrin in 
the proliferative phase maintained their myogenic potential, exhibiting cell fusion 
efficiency and developing an e-c coupling apparatus as in control conditions. Thus, a 
possible hypothetical use of agrin in vitro or in vivo to improve the proliferative capacity 
of resident muscle progenitors would not compromise their successful functional 
differentiation.  
Distribution and effect of endogenous neural agrin in in vivo skeletal muscle tissue 
remains to be ascertained. Even though still not proved at the muscle level, the presence 
of agrin has been detected at perisynaptic and extrasynaptic positions in central 
synapses151-153, suggesting a potential range of action outside the synaptic cleft, where 
neural agrin is released. This together with the evidence that, in rodents and humans 
satellite cells are localized also in the perisynaptic regions and, sometimes, more 
abundant in that area60,154, opens the door to the intriguing hypothesis that neural agrin 
could reach at least the satellite cells in the vicinity of the neuromuscular junction.  
It is also interesting to mention that the content of neural agrin in vivo depends on age. In 
general, agrin concentration depends on the quantity released from the nerve ending in 
an activity-dependent manner and agrin cleavage by the neuronal serine protease 
neurotrypsin155. The reduced physical activity of elderly and massive muscle denervation 
observed especially in humans67,156,157, are only two of the possible reasons of a reduced 
content of neural agrin in muscle. More recently, an increased activity of neurotrypsin has 
been proposed in a subset of human sarcopenic patients133 and the increased serum level 
of one of the fragments generated by neurotrypsin has been proposed as biomarker for 
sarcopenia158.  
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In conclusion, our results suggest that neural agrin is not only an organizer for the 
appropriate assembly of elements at the level of the junctional area, but also a controller 
of a wider range of processes related to the differentiation of the entire cell. Cell 
strategies potentiating the expression of agrin in vivo have been already proposed to 
rescue symptoms in congenital muscular dystrophy159. We can speculate that the 
enhancement in the content of neural agrin in sarcopenic muscle could contribute to 
render the satellite cell niche more permissive for the myogenic precursors, improving 
the regenerative potential of the aged muscle.  
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During the accomplishment of this thesis, the following papers and abstracts have been 
published and presented. 
 
FULL-TEXT PAPERS 
1 Sciancalepore M, Luin E, Parato G, Ren E, Rashid G, Fabbretti E, Lorenzon P. 
Reactive oxygen species contribute to promote the ATP-mediated proliferation of mouse 
skeletal myoblasts. Free Radical Biology and Medicine 53, 1392-1398 (2012). 
2 Gros K, Parato G, Pirkmajer S, Mis K, Podbregar M, Grubic Z, Lorenzon P, Mars T. 
Non-Synaptic Roles of Acetylcholinesterase and Agrin. Journal of molecular neuroscience 
(2013) [Epub ahead of print]. 
 
ABSTRACTS 
1 Parato G, Luin E, Formaggio E, Fumagalli G, Lorenzon P. Neural agrin enhances the 
regenerative potential of aged human skeletal myoblasts. XV Young Neuroscientists 
Meeting, Trieste (Italy), 2011. 
2 Parato G, Pirkmajer S, Marš T, Lorenzon P, Matkovič U..Emerging role for neural 
agrin in human myoblasts proliferation. Molecular Medicine and Biotechnology Congress, 
Ljubljana (Slovenia), 2012. 
3 Lorenzon P, Luin E, Parato G, Sciancalepore M, Bernareggi A. Adenosine-mediated 
modulation of the embryonic isoform of the muscle nicotinic acetylcholine receptor. 63° 
National Congress of the Italian Society of Physiology, Verona (Italy), 2012. 
4 Parato G, Bernareggi A, Luin E, Sciancalepore M, Lorenzon P. Adenosine receptor-
mediated modulation of the nAChR-dependent calcium oscillations in skeletal muscle 
during myogenesis. IIM IX Meeting, Lecce (Italy), 2012. 
5 Mars T, Parato G, Pirkmajer S, Pegan K, Mis K, Matkovič U, Grubic Z, Lorenzon P. 
Non-synaptic roles of acetylcholinesterase and agrin. XIV International Symposium on 
cholinergic Mechanisms, Hangzhou, China, 2013. 
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